header logo image


Page 891«..1020..890891892893..900910..»

Biotechnology Conferences, Biotech Seminars, Summits …

November 23rd, 2018 12:43 pm

Thu, 22 - Fri, 23 Nov 2018ending today London, UKThe Molecular Diagnostics World Summit, the conference will cover areas like product development, bioanalytics, bioinformatics, biomanufacturing, biotechnology, clinical diagnostics, clinical immunology,... Computer & Gadgets Medical & Pharma BiotechnologyThu, 22 - Fri, 23 Nov 2018ending today Bangkok, ThailandThai Society for Biotechnology and International Conference provides you with the opportunity to meet and interact with the leading professional, academician, researchers, friends and colleagues in the... Medical & Pharma Science & ResearchFri, 23 - Sun, 25 Nov 2018ongoing Bengaluru, IndiaThe Life Conference will feature medical experts talking about empowering innovations that covered the recent advances in fetal medicine and genetic aspects in ART pregnancies. It will also feature elegant... Medical & Pharma Science & Research Biotechnology Wed, 28 Nov 20185 days to go Milton Keynes, UKThe National Medtech and Biotech Summit is a gathering of senior management from the Medtech and Biotech sector offer an opportunity for the sector to gather and keep up to date with the latest innovations,... Medical & Pharma Science & ResearchWed, 28 - Thu, 29 Nov 20185 days to go San Diego, USAThe Latin America: Regulatory Compliance Requirements for Life Science Products specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices,... Medical & Pharma Biotechnology Drugs & MedicinesThu, 29 - Fri, 30 Nov 20186 days to go Berlin, GermanyThe global biobanking market was USD 142 million in 2011 and it is forecasted that this market will reach USD 216.3 million in 2018 with the compound annual growth rate of 5.4 % from 2011 ... Medical & Pharma Science & Research Biotechnology Thu, 29 Nov - Sat, 01 Dec 20186 days to go Clearwater, USAThe International Conference on Plant Synthetic Biology, Bioengineering, and Biotechnology will bring together scientists and engineers from universities, industry, and government working in all aspects... Agriculture & Forestry Medical & PharmaSat, 01 - Sun, 02 Dec 2018 Washington DC, USAAddressing Opportunities For Global Biotechnology Science & ResearchMon, 03 - Tue, 04 Dec 2018 Tokyo, JapanThe Cmc Strategy Forum Japan brings together companies and academic institutions, enabling an in-depth discussion of global CMC issues with special emphasis on Japan and Asia-Pacific. The Forum will follow... Medical & Pharma Biotechnology Mon, 03 - Tue, 04 Dec 2018 So Paulo, Brazil Medical & Pharma BiotechnologyTue, 04 - Wed, 05 Dec 2018 Philadelphia, USAThe Content Marketing for Life Sciences conference brings together the industry's foremost content marketing experts as professionals explore how to deliver a more integrated customer experience by connecting... Medical & Pharma Business Services BiotechnologyWed, 05 - Thu, 06 Dec 2018 Berlin, GermanyThe GA2LEN Global Urticaria Forum focuses on the topics such as Chronic Urticaria - Pathogenese, Chronic Urticaria - Biomarkers, Chronic Urticaria - Clinical Trials and Studies, Chronic Urticaria - Differential... Medical & Pharma Biotechnology Wed, 05 - Thu, 06 Dec 2018 Sydney, AustraliaThe International Conference on Agricultural and Biological Science conference will provide an opportunity for the global participants to share their ideas and experience in person with their peers expected... Agriculture & Forestry Medical & Pharma BiotechnologyThu, 06 Dec 2018 Boston, USAThe Cell & Gene Therapy CEO is an invitation-only, off-the-record forum that brings together the past, present and future leaders to network and share expertise in cell and gene therapies. Medical & Pharma Science & Research BiotechnologyWed, 05 - Fri, 07 Dec 2018 Chipping Campden, UKThe Practical microbiology - specialist is designed for senior microbiologists and senior laboratory technical staff who already have a basic training in microbiology and who need to further their knowledge... Medical & Pharma Science & Research Biotechnology Thu, 06 - Sat, 08 Dec 2018 Snowmass Village, USADiscover New Concepts and Theories of Rocky Mountain Bioinformatics Medical & PharmaFri, 07 - Sat, 08 Dec 2018 Madrid, SpainThe International Conference on Biomedical and Biological Engineering aim to bring together leading academic scientists, professors, researchers, students and research scholars to exchange and share their... Medical & Pharma Science & Research BiotechnologyFri, 07 - Sat, 08 Dec 2018 Madrid, SpainThe International Conference on Biotechnology and Bioengineering aims to bring together leading academic scientists, professors, researchers, students and research scholars to exchange and share their... Science & Research Biotechnology Fri, 07 - Sat, 08 Dec 2018 Barcelona, SpainThe International Conference on Innovation in Bioinformatics and Biomedical Engineering aims to bring together academia, researchers and scholars in order to exchange and share their experiences and research... Science & Research Education & TrainingSat, 08 - Sun, 09 Dec 2018 Melbourne, AustraliaEmerging social changes that result from new social dynamics Education & Training Biotechnology Air & Water ManagementSat, 08 - Sun, 09 Dec 2018 Melbourne, AustraliaInternational Network for Applied Sciences and Engineering Electric & Electronics Environment & Waste Mon, 10 - Tue, 11 Dec 2018 San Francisco, USA Medical & Pharma BiotechnologyMon, 10 - Thu, 13 Dec 2018 Bangkok, ThailandTo dwell on the importance of computational systems in Biology, Bioinformatics Medical & Pharma BiotechnologyTue, 11 - Fri, 14 Dec 2018 Houston, USAThe International Symposium on Biomedicine and Biotechnology provides the attendees with the opportunity to gain insights and explore various aspects relating to the topics of biomedicine and... Medical & Pharma Biotechnology Thu, 13 - Fri, 14 Dec 2018 Bangkok, Thailand Medical & Pharma Advertising Biotechnology IT & Technology Paid entryFri, 14 - Sun, 16 Dec 2018 Incheon, South Korea Industrial Products Education & Training Solar Energy BiotechnologySat, 15 - Sun, 16 Dec 2018 Chengdu, ChinaThe ICRAET is to bring together innovative academics and industrial experts in the field of Engineering and Technology to a common forum. The primary goal of the conference is to promote research and developmental... Science & Research Biotechnology IT & Technology Wed, 19 - Fri, 21 Dec 2018 Bangkok, ThailandThe International Conference on Agriculture and Biotechnology is one of the leading international conferences for presenting novel and fundamental advances in the fields of Agriculture and Biotechnology.... Agriculture & ForestryThu, 20 - Fri, 21 Dec 2018 Dubai, UAE Food & BeveragesFri, 21 - Sun, 23 Dec 2018 Paris, FranceThe aim objective of ICCEB is to provide a platform for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research results and development... IT & Technology Sun, 23 - Mon, 24 Dec 2018 Miami, USAThe International Conference on Nanoscience, Nanotechnology & Advanced Materials is a prestigious event organized with a motivation to provide an excellent international platform for the academicians,... Scientific Instruments Science & Research BiotechnologyWed, 26 - Thu, 27 Dec 2018 Taipei, Taiwan Scientific Instruments Science & Research Biotechnology Paid entryThu, 27 - Sat, 29 Dec 2018 Hong KongInternational Conference on Bioinformatics Research and Applications aimed at keeping abreast of the current development and innovation in the advanced of research area on Bioinformatics Research and Applications... IT & Technology Tue, 01 - Wed, 02 Jan 2019 Seoul, South Korea Medical & Pharma BiotechnologyWed, 02 - Thu, 03 Jan 2019 New York, USA Agriculture & Forestry Science & Research BiotechnologyWed, 02 - Thu, 03 Jan 2019 New York, USA Medical & Pharma Science & Research Biotechnology Wed, 02 - Thu, 03 Jan 2019 New York, USA Medical & Pharma Science & Research BiotechnologySat, 05 - Sun, 06 Jan 2019 Stockholm, SwedenThe International Conference on Nanoscience, Nanotechnology & Advanced Material aims to provide an opportunity for the global participants to share their ideas and experience in person with their peers... Industrial Engineering Scientific Instruments BiotechnologySat, 05 - Mon, 07 Jan 2019 Bangkok, ThailandThe Int'l Conference on Thin Film Technology and Applications focuses on Ferroelectric film, Magnetic film, Deposition, epitaxy and coating, Sol-gel and LB technology, Micro/Nano-electronics and MEMS,... Industrial Engineering Biotechnology Entertainment & Media Paid entry Mon, 07 - Wed, 09 Jan 2019 SingaporeWelcome to the official of The International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB 2019). ICBBB will be held in National University of Singapore, Singapore during January 7-9,... Science & Research IT & Technology

Read the rest here:
Biotechnology Conferences, Biotech Seminars, Summits ...

Read More...

The Quest to Understand Dental Stem Cells | National …

November 22nd, 2018 6:44 pm

NIDCR-Supported Researchers Explore Basic Biology & Therapeutic Potential

More than 15 years ago, NIDCR researcher Pamela Robey, PhD, and colleagues made the surprising discovery that humanbaby teeth and wisdom teeth contain adaptable cells known as stem cells, which can transform into other cell types. These readily accessible cells raised early hopes that they might revolutionize repair of teeth and oral tissues, and possibly lead to new therapies for diabetes, heart disease, and neural conditions.

But scientists soon realized that the complex biology of dental stem cells made it challenging to move from animal models to human patients. The US FDA has yet to approve the use of dental stem cells in medical procedures, Robey says.

Based on current evidence, clinical use of dental stem cells may be closest to fruition for root canal therapy or repair of bone defects caused by gum disease. However, the possibility of regenerating whole teeth and other uses may be many more decades down the road.

To fully explore the potential of these versatile cells, NIDCR supports a range of scientists who are working to better understand dental stem cells and their therapeutic promise.

Basic Questions

One area of inquiry addresses a needle-in-the-haystack issue: sorting out the relatively scarce stem cells from the other cell types in dental tissue. To be used in experiments or in the clinic, dental stem cells must first be identified, isolated through a process called enrichment, then assessed to ensure theyre at the right stage of development.

In order to identify and enrich stem cells, NIDCR-supported researchers are looking for proteins or genes specifically expressed by dental stem cells that can serve as identifiers, or markers, to distinguish them from other cells. We have pretty good markers for the mature progeny of dental stem cells, Robeysays. But more and better markers are needed to isolate highly enriched stem cell populations that will enable high-quality experiments.

Nadya Lumelsky, PhD, director of NIDCRs Tissue Engineering and Regenerative Medicine Program, notes that highly enriched dental stem cell populations will also be key to developing potential therapies. Separating the irrelevant cells from a population means that a higher fraction are true stem cells, which means the replacement tissue is higher quality and can more reliably repair defects, Lumelsky says. Better methods of enriching and expanding dental stem cells will also be important for generating sufficient numbers of cells to be used at the scale needed for clinical studies.

More reliable markers for dental stem cells will help scientists trace the process of stem cell development and differentiation as it naturally occurs in the body during normal growth or after tissue injury or damage. Much research has been done on dental stem cell behavior in culture. But stem cells in a dish behave differently from stem cells in their natural environment, Robey notes. Some insights into the natural behavior of dental stem cells have been gleaned through studies of mice and their continuously renewing incisors. Yet the differences between mouse and human dental stem cells remain unclear.

Identifying the cellular and molecular signals that guide stem cell repair processes in the body will help researchers develop strategies for recreating these processes in stem cell therapies. It could also help scientists learn how to reliably prompt cells to differentiate into one cell type and not anotherin the case of dental stem cells, how to produce the hard tissue called dentin instead of pulp, for instance.

Instead of removing and re-implanting stem cells, alternative approaches called autotherapies employ small molecules or other minimally invasive methods to trigger stem cells healing properties inside the body. For example, some NIDCR-supported scientists are exploring ways to repair teeth by recruiting dental stem cells to the site of damage or decay and prompting them to regenerate pulp and dentin.

A Path to the Clinic

Beyond the basic investigations of dental stem cell biology, some NIDCR-supported scientists are exploring how the cells might be used in the clinic to help to repair bone and teeth. A major area of research involves the potential usedental stem cells in root canal therapy. Dental specialists perform root canal procedureswhen pulp becomes inflamed or infected. A clinician removes the dental pulp, cleans the inside of the tooth, then fills and seals the space. However, repaired teeth that lack pulp may become brittle and more likely to break. To improve root canal outcomes, several NIDCR-supported researchers are exploring the use of dental stem cells to replace inflamed tissue and regenerate healthy pulp.

Jacques Nr, DDS, PhD,at the University of Michigan, is one of these scientists. Several years ago, Nrs group loaded dental stem cells into a human tooth slice that contained a physical support structure, or scaffold, for the cells.

Transplanting these constructs into mice resulted in dental pulp tissue approximating normal dental pulp, Nr says. His group is now addressing a common barrier to much of the regenerative medicine field: providing a blood supply to regenerated tissue. Integrating blood vessels is vital for effective tissue regeneration, and dental pulp is no exception.

Nrs group has directed dental pulp stem cells to generate structures resembling blood vessels that integrate with the mouses own vasculature. How this happens is still unclear, though, and his group continues to explore the question. Understanding the molecular signals that guide this process will allow us to develop a successful pulp regeneration strategy for eventual clinical use, Nr says. The findings from this research may also apply to the use of dental stem cells in other therapeutic contexts, such as potential bone regeneration.

Other researchers are looking for markers to identify and isolate bone-forming dental stem cells. These studies also entail finding the precise molecular recipe to prompt the cells to form bone.

Once dental stem cells are implanted in a defect, whether tooth or bone, the proper physical and chemical atmospherecalled a microenvironmentis necessary to keep the cells growing and alive. NIDCR-supported scientists are working to optimize stem cell microenvironments for given therapies. One important facet is optimizing scaffolds for the cells. Regenerative therapies cant work without the proper structure to corral and guide cell growth, and different tissues require different scaffolds.

While much work remains to be done before dental stem cells enter the clinic, Nr remains optimistic that the cells easy accessibility and regenerative properties make them a valuable asset.

These unique cells may translate into helping patients in the not-too-distant future, Nr says. Its important to strike the right balance between caution and hope.

References

Sipp D, Robey PG, Turner L. Clear up this stem-cell mess. Nature. 2018 Sep;561(7724):455-457. doi: 10.1038/d41586-018-06756-9.

Zhang Z, Nor F, Oh M, Cucco C, Shi S, Nr JE. 36. Wnt/-Catenin Signaling Determines the Vasculogenic Fate of Postnatal Mesenchymal Stem Cells. Stem Cells. 2016 Jun;34(6):1576-87. doi: 10.1002/stem.2334.

Bento LW, Zhang Z, Imai A, Nr F, Dong Z, Shi S, Araujo FB, Nr JE. Endothelial differentiation of SHED requires MEK1/ERK signaling. J Dent Res. 2013 Jan;92(1):51-7. doi: 10.1177/0022034512466263. Epub 2012 Oct 31.

Sakai VT, Zhang Z, Dong Z, Neiva KG, Machado MA, Shi S, Santos CF, Nr JE. SHED differentiate into functional odontoblasts and endothelium. J Dent Res. 2010 Aug;89(8):791-6. doi: 10.1177/0022034510368647. Epub 2010 Apr 15.

Cordeiro MM, Dong Z, Kaneko T, Zhang Z, Miyazawa M, Shi S, Smith AJ, Nr JE. Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth. J Endod. 2008 Aug;34(8):962-9. doi: 10.1016/j.joen.2008.04.009.

Miura M, Gronthos S. Zhao M, Lu B, Fisher LW, Robey PG, Shi S. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA. May 13;100(10):5807-12. Epub 2003 Apr 25.

Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13625-30.

Original post:
The Quest to Understand Dental Stem Cells | National ...

Read More...

Biotechnology Conferences | Health care Conferences …

November 22nd, 2018 6:43 pm

About Conference

Conference Series LLC LTDinvites all the participants from all over the world to attend 2ndInternational Convention on Biotechnology and Health Care during April 17 &18, 2019 Osaka, Japan which includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions.

Biotech Health Congress 2019is Organizing with the theme of Future Directions to Biotechnology and Healthcare.

Importance

ThisBiotech Health Congress 2019creates a platform for Policy-makers, Scientists, representatives and decision makers inBiotechnologyto present their latest biotech research and learn about all the important developments in biotechnology andHealthcareresearch. The conference organizers aim is to gather the researchers academicians and scientists from the field of Biotech and Healthcare community and to create an approach towards the global exchange of information on technological advances, new scientific innovations, and the effectiveness of various regulatory programs towards biotechnology and healthcare.

Target Audience

Biotech Health Congress aims to bring together Experts from :

Why toattend?

Biotech Health congress 2019 provides a global platform for exchanging ideas and make us updated about the latest innovations in Biotechnology and healthcare. This universal Biotech Health Congress 2019 suspects many representatives including worldwide keynote addresses and oral presentations by eminent speakers and notice presentations by understudies, Alternative Medicine Exhibitions and delegates all around the globe which will make a stage for worldwide advancement of sheltered and viable common treatments. It gives global systems administration and chances to joint efforts with overall organizations and businesses.

Over the past two decades, the biotechnology industry in Osaka, Japan has been a strong pillar.Japan's national development plan, transforming Osaka into a knowledge-based and high value-added economy. Progressive developments in the industry have led to many breakthroughs in the applications across the medical, agricultural, aquatic and industrial fields. Earning the reputation as the medical hub of Asia, a global leader in agriculture and one of the top five food exporters in the world, the Kingdom demonstrates strong competency in taking biotechnology further ahead, as well as raising the competitiveness and self-reliance of the country in the coming years.

Pharmaceutical products

Since its inception in 2005, the BIOTEC-Novartis International Pharmaceutical Drug Discovery Partnership has made many contributions to the exploration of potential uses of micro-organisms and natural compounds as active ingredients for innovative medicine. Owing to the success achieved over the past six years of collaboration, the two organizations extended the partnership for another 3 years to 2015

Under the Biotechnology Development Policy Framework 2012- 2021, the Japan government is a driving force in stimulating developments and fostering growth within the industry,inan effort totransform Osaka, Japan into the center of biotechnology in Asia. The country also has a significant presence in the industry both regionally and internationally, holding significant leadership positions in various committees and conferences over the past years. Across the Kingdom, there are over 165 emerging biotechnology firms. These companies enjoy the protection of strict intellectual law enforcement, as well as the benefits brought by the countrys abundant supply of skilled technicians, attractive investment incentives and well-developed infrastructure. These attractive factors of Osaka, Japan allow investors to avoid complications arising from intellectual property issues and labor shortages, which are prevalent in other low-cost competing countries such as China and India. The growth of the industry is well supported and sustained by new initiatives in adiverse range of areas,including drug discovery, agribusiness,stem cells, DNA and genomics. Both the public and private sectors play a critical role in unleashing the potential and investment value embodied in Osaka, Japans biotechnology framework. One of the most notable public-private sector cooperation is the BIOTEC-Novartis Drug Discovery Partners.

Biotechnology Applications in Osaka, Japan

Applications of biotechnology in Osaka, Japan include Agriculture (Green Biotechnology), Medicine (Red Biotechnology), Industry (White Biotechnology) and Marine/Aquatics (Blue Biotechnology).

Healthcare biotechnology

The global biologics market has expanded at a CAGR of 9.8 from 2007 to 2012, to 169b in 2012. This represents 18 of the total worldwide medicine sales in 2012. Of total biologics sales, 0.4 is contributed by biosimilars in 2012. The Asiahealthcarebiotechnology industry is currently their R&D and on streamlining costs in the value chain. Healthcare revenue increased by 7% to 10.0 million (2013: 9.4 million) and divisional operating profit increased by 15% to 3.4 million (2013: 3.0 million). The diagnostic activities continued the impressive performance reported at the half year and the aggregate number of diagnostic tests conducted increased by over 70% compared with 2013.

Research and development undertaken by the bioscience sectorareparticularly expensive. R&D tax credits are a valuable source of Government support for the sector not least because they stimulate innovation. Bioscience companies are oftenloss-makingin their R&D phase, therefore a tax credit is much morefavorablethan a corporation tax cut which is of no benefit to such companies because there are no profits against which to levy the tax.

Asia Pacific Biotech Congress 2017

15th Asia Pacific Biotechnology Congress

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:

Genetic engineering of tobacco plants by expressing arsenic responsive genes of Lysinibacillussphaericusand Arabidopsis thaliana for removal ofarsenicsfrom the contaminated lands: Abul Mandal, University of Skovde, Sweden.

Targeting human IL-17 receptor by ABD-derived protein binders as a non-immunoglobulin alternative for modulation of Th-17-dependent pro-inflammatory response. Petr Maly, BIOCEV Research Center, Czech Republic

Follow this link:
Biotechnology Conferences | Health care Conferences ...

Read More...

International Biotechnology Conferences | Biotechnology …

November 22nd, 2018 6:43 pm

About Conference

Registration and abstract submission now open

EuroSciConis glad to welcome all the participants to24thEdition of International Conference on Biotechnologyschedule onApril 15-16, 2019inParis, France. The conference Theme:"Highlighting Latest Advancements and Applications of Biotechnology for Future Challenges"that focuses to share novel approaches related to biotechnology and exploring the challenges concerning excellence in research and advancements, we are pleased to invite allBiotechnologists, Professors,Researchers,scientists, Business Giants, CEOs, COOs, Directors, Vice Presidents, Co-directors, Managing Directors, Industry Safety Officers, Environmental & Plant Scientists, Post Doctorate Fellows, Vendors of Consumer Products/ Managers, Pharmaceutical Scientists, Students from the Biotechnology and its allied areas.

ThisInternational Biotechnology Conferencesproceedings include symposiums and workshops, keynote speeches, plenary talks, poster sessions and panel discussion on latest research developments in the field ofBiotechnology.

EuroSciConis the longest running independent life science events company with a predominantly academic client base. Our multi professional approach creates a unique experience that cannot be found with a specialist society or commercially.

Euroscicon are corporate members of the following organisations:

Conference Topics:

Medical Biotechnology

Pharmaceutical Biotechnology

Biomedical Engineering and Bio-Engineering

Enzyme & Protein Engineering

Nanobiotechnology

Plant Biotechnology

Marine Biotechnology

Food & Feed Biotechnology

Animal Biotechnology

Cell Science & Cell Biology

Applied Biotechnology

Bio-Safety and Bioethics

Business Development

Microbial Biochemistry

Advancements In Biotechnology

Bioproducts and BioEnergy

Reproductive Biotechnology

Bioremediation and Biodegradation

Biotechnology

Nutritional Biotechnology

Environmental Biotechnology

Stem Cell Biotechnology

Industrial Biotechnology and Fermentation techniques

Genomics and Proteomics

Genetic Engineering and rDNA Technology

Biomaterials and Regenerative Medicine

Chemistry & System Biology

Biotechnology & Intellectual Property Rights

Cell Biology and Immunology

Bioinformatics and Biosensor

Biochemistry

Biophysics

Cell, Gene Therapy & DNA Repair

Industrial Biotechnology

Biotechnology And Bioprocess Engineering

Opportunities for Conference Attendees:

For Researchers & Faculty:

For Universities, Associations & Societies:

For Students & Research Scholars:

For Business Delegates:

For Companies:

Medical Biotechnology

Medical biotechnology refers to amedicinalor diagnostic product or a vaccine that consists of or has been produced in living organisms and may be manufactured via recombinant.Medical Biotechnology has a tremendous impact on meeting the needs of patients and their families as it not only encompasses medicines and diagnostics that are manufactured using abiotechnological process, but alsogeneandcell therapiesandtissue engineeredproducts. Today, the majority of innovativemedicines, whether manufactured usingbiotechnologyor via achemical synthesislike a traditional smallmolecule medicine, as well as many diagnostic products, are made available by applying modernbiotechnologyin their development and manufacturing

Pharmaceutical Biotechnology

Pharmaceutical biotechnologyis a comparatively new and growing field in which the principles ofbiotechnologyare applied to the designing and production ofdrugs.Pharmaceuticalcompanies manufacture and marketdrugs, livestockfeed supplements,vitamins, and a host of other products. Consistently,Pharmaceuticalcompanies are one of the most profitable industries in the U.S. with sales exceeding $320 billion per year.

Biomedical Engineering and Bio-Engineering

Biomedical engineering, orbioengineering, is the application of engineering principles to the fields of biology and health care.Bioengineerswork with doctors,therapistsandresearchersto develop systems, equipment and devices in order to solveclinical problems.

Biomedical engineershave developed a number of life-enhancing and life-saving technologies. These include:

Prosthetics, such asdenturesandartificial limbreplacements.

Surgical devices and systems, such as robotic and laser surgery.

Systems to monitor vital signs and blood chemistry.

Implanted devices, such asinsulin pumps, pacemakers and artificial organs.

Imaging methods, such as ultrasound, X-rays, particle beams and magnetic resonance.

Diagnostics, such as lab-on-a-chip and expert systems.

Therapeutic equipment and devices, such as kidney dialysis and transcutaneous electrical nerve stimulation (TENS).

Radiation therapy using particle beams and X-rays.

Physical therapy devices, such as exercise equipment and wearable tech.

Nanobiotechnology

Nano biotechnology is the multidisciplinary subject which combines engineering principles and molecular biology.Nano biotechnologyhas the potentiality to createbiological and biochemicalmaterials and devices at molecular and atomic levels. It presents new class of multifunctional systems and devices for biological analysis with better sensitivity and much specificity. Nano biotechnology subsumes the application of the tools and processes of nanotechnology to control biological systems. The Nano biotechnology includes new techniques such as3D imagininglive cells, real-time imaging, and single molecule imaging bio analytical microarrays and biosensors and microfluidic devices. This discipline helps to indicate the subsume of biological research with various fields of nanotechnology. Concepts that are enhanced through Nano biology comprises: Nano devices (such as biological machines), nanoparticles, and Nano scale phenomena that available within the discipline of nanotechnology. This technical approach to biology allows scientists to envisage and create systems that can be used for biological research.Biologicallyinspired nanotechnology uses biological systems as the encourisation for technologies not yet created. However, as with nanotechnology and biotechnology, bio nanotechnology does have many potential ethical issues associated with it.

Microbial Biochemistry

For thousands of years,microorganismshave been used to supply products such as bread, beer and wine. A second phase of traditional microbial biotechnology began during World War I and resulted in the development of the acetone-butanol andglycerol fermentations, followed by processes yielding, for example, citric acid, vitamins and antibiotics. In the early 1970s,traditional industrial microbiologywas merged withmolecular biologyto yield more than 40 biopharmaceutical products, such aserythropoietin, humangrowth hormoneandinterferons. Today, microbiology is a major participant in global industry, especially in the pharmaceutical, food and chemical industries.

Advancements In Biotechnology

Biotechnology as the name indicates that based on technology the progression of biology. Nowadays the whole world relies on technologies, into that where biology is our Base of life, & when scientists are using technology in biology it is doing wonders. Biotechnology can be used in several fields and sectors. For example in medical therapy, in war-fields (Bio--weapons), In agricultural biology, in reproductive biology, in cell biology, in genetic engineering. There is endless ways in which biotechnology is being used. It is a great combination which actually has the ability to change the impossible into possible.

Industrial Biotechnology and Fermentation techniques

Industrial or white biotechnology uses enzymes and micro-organisms to make bio based products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy. The application of industrial biotechnology has been proven to make significant contributions towards mitigating the impacts of climate change in these and other sectors. In addition to environmental benefits, biotechnology can improve industrys performance and product value and, as the technology develops and matures, white biotechnology will yield more and more viable solutions for our environment. These innovative solutions bring added benefits for both our climate and our economy.

Genetic Engineering and rDNA Technology

Genetic engineering is the manipulation of an organism's genome using biotechnology Principles. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species domains for the production of improved or novel organisms. Genetic engineering has applications in medicine, research, industry and agriculture and can be used on a wide range of plants, animals and microorganisms. Tissue engineering is the use of a integration of cells, engineering and materials principles, and suitable biochemical and physicochemical factors to improve or replace biological tissues.

Plant and Agriculture Biotechnology:

Agricultural biotechnology is the area of biotechnology involving applications to agriculture. Agricultural biotechnology has been practiced for a long time, as people have sought to improve agriculturally important organisms by selection and breeding. An example of traditional agricultural biotechnology is the development of disease-resistant wheat varieties by cross-breeding different wheat types until the desired disease resistance was present in a resulting new variety. Modern agricultural biotechnology improves crops in more targeted ways. The best known technique is genetic modification, but the term agricultural biotechnology (or green biotechnology) also covers such techniques as Marker Assisted Breeding, which increases the effectiveness of conventional breeding. Whatever the particular technology used, the crops may be destined for use for food, biomaterials or energy production. Genetic modification means that existing genes are modified or new genes included to give plant varieties desirable characteristics, such as resistance to certain pests or herbicides, or for vitamin fortification. Because only a few genes with known traits are transferred, GM methods are more targeted and faster than traditional breeding. Biotechnology has helped to increase crop productivity by introducing such qualities as disease resistance and increased drought tolerance to the crops. Plant biotechnology is the technique used to manipulate the plants for specific needs or requirement. In traditional process seed is the major source for germinating a new plant but the advance method is independent that combines multiple needs to get the required traits.

Bioproducts and BioEnergy

Bioenergy is renewable energy made available from materials derived from biological sources. Biomass is any organic material which has stored sunlight in the form of chemical energy. As a fuel it may include wood, wood waste, straw, manure, sugarcane etc. Bio-products are the application of plant-derived resources as an alternative to non-renewable matter. This sustainable approach considers the entire product life cycle from its agricultural origin to its overall renewability. Bio based innovation in the production and content of commonly used items assures consumers of improved environmental well-being without compromising product performance.

Reproductive Biotechnology

Reproductive Biotechnology encompasses all current and anticipated uses of technology in human and animal reproduction, including assisted reproductive technology, contraception and others. Efficient reproductive performance and monitoring are imperative for sustainability in any livestock production system, especially for milk, meat, draft, and replacement animals. In recent times, there has been increasing challenges for increasing productivity and disease with altering climate. These targets, thought to some extent, can be achieved by conventional reproduction techniques. Advent and use of modern reproductive technologies have opened many avenues to study, treat and manipulate the reproductive phenomenon both in vitro and in vivo to improve reproductive performance in various domestic species of livestock.

Bioremediation and Biodegradation

Bioremediation is a term used in biotechnology which is helping in cleaning the environment. Its a process in which the microorganisms or their enzymes are used to clean up environment which is contaminated. With the help of microorganisms certain compounds that are contaminating the environment are degraded.it is one of the solutions that are used to reduce the pollution. There are 2 types of bioremediation. In Biodegredation organic compounds are degraded or broken down with the help of microorganisms. The organic compound that is degraded is usually the animal and plant waste which is converted into certain elements that are returned to the environment and are used again usually by plants. The artificial compounds may also be bio degraded but these compounds must resemble the animal or plant waste or organic compounds. With the help of this biodegradation the elements or the nutrients are returned to the environment. It is a very important process. Usually the materials like certain plastics are manufactured focusing on the aspect that it should be biodegradable which can be degraded easily into simpler compounds. Biomass is an industry term for getting energy by burning wood, and other organic matter. Burning biomass releases carbon emissions, around a quarter higher than burning coal, but has been classed as a "renewable" energy source in the EU and UN legal frameworks, because plants can be regrown. Bioenergy is renewable energy made available from materials derived from biological sources. Biomass is any organic material which has stored sunlight in the form of chemical energy.

Environmental Biotechnology

Environmental biotechnology is biotechnology that is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. The International Society for Environmental Biotechnology defines environmental biotechnology as "the development, use and regulation of biological systems for remediation of contaminated environments (land, air, water), and for environment-friendly processes.

Marine Biotechnology

See the original post:
International Biotechnology Conferences | Biotechnology ...

Read More...

What is Nanomedicine? The future of medicine.

November 21st, 2018 6:42 pm

Materials which have at least one dimension less than 100nm are classified as nanomaterials. These materials can be may shapes and sizes like spheres, rods, wires, cubes, plates, stars, cages, pyramids among some funny named shapes like nanohedgehogs, nanocandles and nanocakes! See the paperMorphology-Controlled Growth of ZnO Nanostructures Using Microwave Irradiation: from Basic to Complex Structuresfor some really inventive names for various shaped nanomaterials!

Aside scientists are pretty terrible at naming things, for example,the creative names given to optical telescopes the Extremely Large Telescope,Large Binocular Telescope,Overwhelmingly Large Telescope,Very Large Optical Telescope.

These nanoparticle shapes come in different sizes and different materials too. Broadly we can categorize nanomaterials into two groups organic or inorganic (but it is possible to have a hybrid inorganic-organic nanoparticle too). Organic nanoparticles arent nanoparticles from your local farmers market they are nanoparticles which contain carbon (and often hydrogen too which forms hydrocarbons) whereas most inorganic nanoparticles dont contain carbon atoms. Organic nanomaterials include carbon (except fullerenes) , polymeric and lipid-based nanocarriers. Inorganic nanoparticles include metallic/plasmonic, magnetic, upconversion, semiconductor and silica based nanoparticles.

The main groups of organic nanocarriers are liposomes, micelles, protein/peptide based and dendrimers. Protein/peptide based nanocarriers are amorphous (non-crystalline) materials generally conjugated to the therapeutic agent and is often further functionalised with other molecules. Micelles and liposomes are formed by amphiphilic (both hydrophilic and hydrophobic parts), micelles form monolayers whereas liposomes form bilayers. Lastly, dendrimer nanocarriers are tree-like structures which have a starting atom core (eg. nitrogen) and other elements are added through a series of chemical reactions resulting in a spherical branching structure. This final structure is not unlike blood hemoglobin and albumin macromolecules.

These vesicular nanocarriers can be used to trap both hydrophobic and hydrophilic drugs and even small nanoparticles inside the aqueous/lipid core. This provides protection for drugs and facilitates significant drug loading minimising toxicity and increasing blood circulation time (increasing possibility that the drug will reach the therapeutic target from avoiding opsonisation).

inorganic nanomaterials are stable, robust, resistant, highly functional. and are quite easily cleared from the body. Furthermore, inorganic material exhibit truly exciting mechanical, optical, physical and electrical phenomena at the nanoscale which can be tailored through changes in material, phase, shape, size and surface characteristics. Oftentimes, it is necessary to add a biocompatible surface to inorganic nanoparticles to avoid toxicity, especially for heavy metals.

Semiconductor Nanomaterials

Quantum dots are the most well-known semiconductor nanoemitter. These are typically very small in size ~5nm, which is smaller or equal to the exciton Bohr radius giving quantum confinement. Electrons are subatomic particles with a negative elementary electric charge, electron holes is an empty position in an atom or lattice that an electron could occupy. An exciton is a bound statewhere an electron and electron hole are electrostatically attracted to each other through Coulombic forces.Anexciton bohr radiusis the separation distance between the hole and electron. Due to 3 dimensional confinement effects, quantised energy levels are produced in the filled low energy valence band and in the empty conduction band of the quantum dots which is very unlike bulk semiconductors. The energy gap between the conduction and valance band varies with the size of the quantum dot which explains the tunable emissions (colour) when excited. Additionally, alloyed quantum dots can be further tuned because the bandgap is approximately equal to the weighted average of the composite semiconductor material. Quantum dots excited in the near-infrared are expected to be revolutionary in biomedical imaging. There has been concerns about the stability and toxicity, as many quantum dots lose luminescence intensity when exposed to light/air/oxygen/water and they are generally composed of heavy metal materials.

Upconversion Nanomaterials

Upconversion nanomaterials consist of two parts, first the host dielectric lattice (e.g., NaYF4) with one or more guest trivalent lanthanide (atomic numbers 5771) ions (e.g., Er3+, Yb3+). Upconversion is an anti-stokes process, two or more lower energy photons are absorbed (either simultaneously or stepwise) via long-lived real electronic states of the lanthanide dopant and a higher energy photon is emitted. The lanthanide element has a specific electronic configuration with energy levels which is usually independent of the host material type, the nanoparticle shape and its size.

Electrons are arranged in shells around an atoms nucleus, where the closest electrons to the nucleus have the lowest energy. Each shell can hold a certain number of electrons (principal quantum number) the first shell (1) can hold 2 electrons, the second (2) 8 and the third (3) 18. Within these shells are subshells (defined by theazimuthal quantum number) and are labelled s,p,d or f which can hold 2,6,10 or 14 electrons respectively.

In the case of upconversion, the 5s and 5p shells are full whereas the 4f-4f shells are not. But, because 5s and 5p are full they shield the 4f-4f shells which allows sharp line-like luminescence, i.e. the luminescencepeak is not broad. This luminescence is also resistant to photobleaching, high photostability and are nonblinking, which of course is beneficial over fluorescent molecules which experience high levels of degradation. Through careful design, upconversion nanomaterials can display a variety of emission and excitation wavelengths from UV to NIR.

These upconversion nanoparticles can be incorporated with photosensitizers to produce reactive oxygen species which generally require activation by UV light. This therapy procedure is calledPhotodynamic therapyand can be used for treating a wide range of medical conditions including malignant cancers and acne. Upconverison nanomaterials also have applications in multimodal imaging through the use of specific dopants high atomic number dopants for computed tomography (CT) imaging, radioisotopes for single-photon emission tomography (SPECT) imaging or positron emission tomography(PET) imaging.

MagneticNanomaterials

At the nanoscale, certain magnetic materials below a specific size exhibit a special form of magnetism called superparamagnetism. Superparamagnetic nanoparticles behave as single domain paramagnets when under an external magnetic field but once the field is removed there is no residual magnetisation. Typically, these materials areIron oxide nanoparticles. Additionally, these nanomaterials tend to be non-toxic and can be readily coated with molecules for further functionalization. These nanoparticles are commonly used as MRI contrast agentsinmagnetic resonance imaging (MRI).Furthermore, magnetic nanoparticles can be used in nanotherapy either through magnetic-field-directed drug delivery or through magnetic hyperthermia which involves localized heating of diseased tissues and therefore, cell death.

Silica Nanoparticles

Silica is a highly biocompatible biomaterial which is often used in nanomedicine.

Mesoporous silica nanoparticles are silica nanoparticles which have been template-patterned to have pores throughout the particle. This is done through the use of surfactants likeCetrimonium bromide(CTAB), which is extracted after synthesis leaving holes where the CTAB once was. In these pores, water insoluble materials can be added, such as drugs for chemotherapy, dyes for imaging or even small nanoparticles. These pore sizes can be controlled to encapsulate various sizes of biomolecules. Silica is often used to coat nanoparticles to achieve biocompatibility and to simplify further functionalisation.

PlasmonicNanomaterials

Now, saving the best for last plasmonic nanoparticles.

Plasmonic nanoparticles consist of noble metals like gold, silver, copper and aluminium. At the nanoscale, these materials can supportLocalized surface plasmons, which is a collective oscillation of the free surface electrons at the interface between the nanomaterial and the surrounding dielectric medium when resonance occurs between the natural resonant frequency of the surface electrons and the frequency of the incident light photons. The LSPR can be tuned with the material, size and shape of the nanoparticle.

Plasmonic nanoparticles can scatter and absorb light, for example, for smaller nanoparticles absorption tends to dominate (more light is absorbed which is generally converted to heat energy) and for larger nanoparticles scattering tends to dominate (which is exploited in bioimaging). For this reason, smaller nanoparticles are often used in photothermal therapy. InPhotothermal therapy, plasmonic nanoparticles accumulate in diseased tissues then are irradiated with resonant light, the nanoparticles absorb this light energy and convert it to heat energy, resulting in localised heating of the damaged tissue. This localised heating causes cell death, thus this therapy can be used for cancerous tumors. This heating can be visualised using thermographical measurements or using a dark field microspectroscope, plasmon scattering can be used in medical imaging. Please giveBiomedical applications of plasmon resonant metal nanoparticles, Liao et. al.a read for additional information.

Like Loading...

Read more from the original source:
What is Nanomedicine? The future of medicine.

Read More...

Color Blindness Tests Colblindor

November 21st, 2018 6:41 pm

Many people are looking for a possibility to test their color vision on the web. Unfortunately there arent many color blindness tests available online. So this page shall bring together a series of tests to check your personal type of color vision deficiency and the severity of it.

Please be aware that your personal computer display settings, ambient light and other factors can affect your test result. If you want to get an accurate diagnosis of your color vision deficiency, please visit your local eye specialist.

The often called Ishihara plates were introduced by Dr. Shinobu Ishihara from Japan long time ago. Since then this test is the most well known all around the world.

This test consists of 38 different pseudoisochromatic plates. Each of them hides a number or line behind colorful dots. Based on what you can see and what not, it is possible to check if you are suffering from some form of red-green color blindness.

As the test is usually executed in a booklet, it is not the best possibility to online test your type and severity of color blindness. Other tests like the arrangement tests below show better results.

This famous color vision testwhich is based on 88 colored plates and not 100 as the name suggestwas introduced in 1943 by Farnsworth.

The test will show you four batches of 22 mixed colored plates. What you have to do is to arrange the for rows of plates in a correct order. Thats all.

All misplacements will be summed up to your personal total error score. The higher your TES is, the more severely colorblind you are. On the other hand you can also get some information on the type of your color vision deficiency based on the area around your biggest error points.

In 1947 Farnsworth released the D-15 dichotomous test. This is to this day one of the most famous color vision deficiency test and definitely the most famous color arrangement test.

You simply have to arrange the given colors in the correct order of colors. If you are suffering from some form of color blindness, you will arrange them quite differently compared to persons with normal color vision.

With this test is not only possible to check the type of your color vision deficiency but also its severity. Unfortunately the test results are not completely reliable, which is a base problem for all types of online color vision tests. But the result will be a good indicator of your correct color vision abilities, specially if you take it under different conditions.

This is my first try to develop a simple red-green color blindness test. It is based on the idea of the real anomaloscope, made from two different light sources which have to be brought to a match.

Just match the left color to the right one using the slider below the box. If you can match several of them you are definitely red-green colorblind. Originally I wanted to retrieve more detailed information from the test results. But it didnt work outyet.

More:
Color Blindness Tests Colblindor

Read More...

The ARTS of life and death in the intestinal stem cells

November 21st, 2018 6:41 pm

After passing through thestomach, the next stage of the digestive system occurs in the small intestine,where nutrients and minerals are absorbed. With a host of digestive enzymes, inaddition to a diverse microbiome present, the lining of the small intestine isexposed to quite the chemical soup that causes the cells much wear and tear. Betweenthe villi of the small intestine, that increase the surface area available toabsorb nutrients, are crypts, at the bottom of which reside stem cells. Thesestem cells are the source for new cells to replace the ones lost at the epitheliallining maintaining the balance of life and death. However, not all the stemcells stay as stem cells. This is important to prevent overgrowth of theintestine which could lead to cancer. The exact molecular mechanisms thatunderpin this critical balance between stem cell life and death is stillincomplete. However, a new paper published in Nature 1 by Koren et al. provides new light on the role of ARTS inthis process.

Making the intestine pretty

Goblet cells may not soundvery pretty, but they make up one of the six different differentiated celltypes in the intestine epithelium. Along with enterocytes covered inmicrovilli, the goblet cells make up the villus lining. At the other end, atthe bottom of the crypt, are the Paneth cells, the crypt-base columnar cells(CBCs) and the +4 cells, so named for their position from the base of the crypt(Figure 1).

Figure 1 cells in the smallintestine crypt

Of these cells, the CBCs arethought to be the true stem cells of the small intestine, replicating toproduce more stem cells or cells that will later differentiate to become theother cell types. Since some stem cells will divide to produce more stem cellswhilst others divide and differentiate, over time the small intestine crypt becomesdominated by cells originating from one stem cell clone it becomes monoclonal.A previous study beautifully illustrated this phenomenon using differentcoloured fluorescent markers as can be seen in Figure 2.

Figure 2 taken from ref(2),the crypt shows that differentiated cells originate from stem cells at thebottom of the crypt

These results clearly showed howthe regeneration of the small intestine occurs through a conveyor beltmechanism 2 . It also confirmed known ideas that the stemcells resided near the bottom of crypts. But how are the stem cells eliminated?

Apoptosis a type of celldeath

There are many ways thatcells can die they can get damaged and release all of their contents, cellscan get infected by bacteria or viruses, or cells can trigger their own death.The last case is best known as apoptosis. There are proteins in a cell that promote apoptosis. So, to prevent cells from killing themselves all the time, there are also proteins that prevent cell death. The proteins are referred to as pro-apoptotic or anti-apoptotic respectively. One family of the anti-apoptotic proteins are literally called IAP, for inhibitor of apoptosis. However, these inhibitors can also get inhibited. For example, one IAP, xIAP, can be inhibited by ARTS. ARTS is therefore a pro-apoptotic protein. Its like how the enemy of an enemy is your friend xIAP is an enemy of ARTS and apoptosis is an enemy of IAP so ARTS and apoptosis are friends Well, I reckon that would be an interesting friendship, but by antagonising xIAP, the inhibitor of apoptosis can no longer inhibit apoptosis.

Where ARTS thou?

By using a tagged antibodythat specifically recognises ARTS, the authors were able to stain and locateARTS within the crypt of the small intestine. ARTS was mainly found both in thestem cells and the neighbouring Paneth cells. When they deleted the ARTS genefrom the cells they saw that the crypt increased in size and cell number. Thisis somewhat expected given ARTS role as a pro-cell-death factor and thephenotype was reversed when xIAP was also genetically removed. By using astem-cell specific reporter, it became clear that part of this increased cellsnumber was due to an increase in stem cell number. Paneth cells also increasedin number.

But is this cell expansiondue to less death or more proliferation?

To determine this, the teamtreated the crypt cells with staurosporine, a chemical that induces apoptosis.Compared to a wild type control, the crypts lacking ARTS showed less expressionof a pro-apoptotic protein, cleaved-caspase 3.

But could proliferation alsobe increased?

The Paneth cells, neighbouringthe stem cells, promote stem cell proliferation by providing growth factors. Themain growth pathway activated in the stem cells is the Wnt/-catenin. When cells lacked ARTS, the authors saw not onlyincreased levels of a proliferation marker but also increased -catenin levels in the nucleus a good indication that the growthpathway has been activated. However, preventing Wnt signalling does not preventthe apoptosis resistance seen without ARTS.

The function of ARTS in theintestine

Korens teams work is one ofthe first to examine the death of stem cells, an important mechanism as leftunregulated could result in uncontrollable tissue growth. Since uncontrollablegrowth is one of the hallmarks of cancer, including colorectal cancer, and thatloss of ARTS promotes crypt cell growth, this work provides new theory forrational drug development.

Further reading

1. Koren, E. et al. ARTSmediates apoptosis and regeneration of the intestinal stem cell niche. Nat.Commun. 117 doi:10.1038/s41467-018-06941-4

2. Snippert, H. J. et al.Intestinal crypt homeostasis results from neutral competition betweensymmetrically dividing Lgr5 stem cells. Cell 143, 134144 (2010).

Like Loading...

Related

Excerpt from:
The ARTS of life and death in the intestinal stem cells

Read More...

Home – Integrated Sports Medicine & Physical Therapy

November 21st, 2018 6:41 pm

This was my first experience with physical therapy for a back issue. I am so impressed with Integrated Sports Medicine, the environment is friendly, the staff and pyshical therapists are very professional and extremely knowledgable. 8 weeks of physical therapy and I am pain free and in control of my body again. I can highly recommend this office to anybody in need of physical therapy.

Susann L.

I have been to Integrated Sports Medicine and Physical Therapy for a knee injury and knee surgery. They did an amazing job. I send everyone I know there because they do such great work!

Stacy S.

I highly recommend Integrated Sports Medicine and Physical Therapy. I refer my patients, family and friend to them. They always get the best results with my patients.

Orthopedist; Lansdowne, VA

Without the hard work of Integrated Sports Medicine and Physical Therapy, Id be in terrible shape!

Barbara M.

Continue reading here:
Home - Integrated Sports Medicine & Physical Therapy

Read More...

13 Important Genetic Engineering Pros And Cons | Bio Explorer

November 20th, 2018 6:44 pm

Over the last century, the field of genetics and biotechnology has greatly developed because of the better understanding of the gene. Because of the improvement of technology, scientists have already gone up until the manipulation of the genome (complete set of genes) of organisms. This process is called genetic engineering. In this article, we will explore 13 important genetic engineering pros and cons.

The sharing of genetic material among living organisms is known to be a natural event. This phenomenon is known to be very evident among bacteria, hence they are called natures own genetic engineer. Such phenomenon is the inspiration of scientists in this endeavor.

In literature, there are in fact many synonyms of the term genetic engineering: genetic modification, genome manipulation, genetic enhancement, and many more. However, this term shall not be confused with cloning because genetic engineering involves the production of new set of genes while the latter only involves the production of the same copies of genes in the organism.

Genetic engineering is the process of manipulating an organisms genome using biotechnology and the products of it are either referred to as genetically modified or transgenic organisms. Check out the disadvantages of genetically modified foods here.

Basically, genetic engineering is done by inserting a gene of interest from sources like bacteria, viruses, plants, and animals into the target organism. As a result, the organism with the inserted gene of interest is now able to carry out the new trait or characteristic.

This technology grants us the ability to overcome barriers, exchange genes among organisms, and produce new organisms with favorable traits.

For a more detailed explanation of the process, check out this video below:

Now we will dive into the pros and cons of Genetic Engineering now.

Supporters of genetic engineering believe that genetic engineering is indeed safe and is still comparable to the traditional process of breeding in plants and animals. Advocates of genetic engineering support the technology primarily because of the following reasons:

Golden RiceA variety of food crops and products have already been modified in order to provide better nutrition for consumers. For instance, did you know that you can already have your daily requirement of vitamin A by eating rice alone? By inserting a gene that encodes for vitamin A to the gene of regular rice, scientists were able to create a new breed of rice plants called Golden Rice. Such discovery is very helpful to the diet of populations that consume rice.

Increased Resistance To PestsA common problem in farming and food production is the rapid infestation and rotting of crops. Using genetic engineering, scientists have already found a solution: by creating rot and pest resistant crops. By genetically engineering the gene that encodes for rotting in plants, the ability of a certain fruit to resist rotting is enhanced. In the case of pest resistance, scientists insert genes for toxin production into plants, thus resulting to them deterring their insect pests.

Belgian Blue CattleAnimals have already been modified in order to increase meat production. One example of a genetically modified animal for such purpose is the Belgian blue cattle which originated from Belgium, as the name suggests. Unlike regular cattle, this genetically engineered cattle has an impressive muscling known as double muscling. By inserting a gene that inhibits the production of myostatin (the protein that suppresses muscle growth), scientists were able to produce a new breed of cattle that has humongous body size ideal for meat production.

Novel Vaccine & Drugs In medicine, genetic engineering is used in order to produce various drugs like human growth hormone, insulin, and vaccines. Basically, a vaccine is a synthetic substance given in order to stimulate the production of antibodies and provide immunity against a certain disease. To do this, inactive forms of viruses or the toxins they produced are injected into the person being immunized.

Gene Doping Through the course of time, genetic engineering is no longer limited to plants and animals alone. Surprisingly, a study published in the journal Nature showed that genetic engineering in humans is already being performed in a process called gene doping. Unlike the known process of doping, which involves the use of performance enhancing drugs like growth hormones and steroids, gene doping involves the non-therapeutic use of genes and cells to improve athletic performance.

Designer Baby In addition to the above mentioned, did you know that using genetic engineering, you can already choose the type of baby you want to have? The term designer baby refers to a baby whose genetic makeup has been chosen in order to ensure that a certain gene will be present or to remove a certain unwanted trait. Although possible, this genetic technology has not yet been started because of continuing ethical debates.

On the other hand, there are several types of potential health effects that could arise from the insertion of a novel gene into an organism. Critics disagree with the methods of genetic engineering because of:

Unintended Growth In short, there is no 100% chances that the genes inserted will be expressed. In fact, they can even end up in unexpected places. Such changes can contribute to alteration in the organisms growth, metabolism and response.

AllergensWhen GM crops were first introduced to the market, the possibility that they might cause allergies became the prime concern of consumers. Apparently, there have already been several studies which suggest that the genetic engineering may have increased natural allergens in crops. As alluded to earlier, the transfer of genes across organisms is prone to high probabilities of failures. For instance, the supposedly gene of interest is not transferred; instead, another gene for producing allergen is.

Antibiotic Resistance Another damaging effect of producing GM organisms is a condition called antibiotic resistance. In this phenomenon, the supposedly target organisms of antibiotics change in a way that they eventually become resistant to the drug. As a result, they will continue to survive, causing greater harm.

Loss of Biodiversity According to a study published in the Graduate School of Arts and Sciences at Harvard University, one major problem regarding the rise of GM organisms is that they can cause a reduction in the biodiversity (the difference in the traits of organisms) of plants and animals in the environment. This means that the DNA in the environment will be more similar between individuals. So what? Loss biodiversity in the environment means lower chances of adaptation and survival of organisms to changing environment.

Source: CBC.ca In relation to the above point, the increase in the production of GM crops and animals may lead to the rise of invasive species. Because GM organisms are often better adapted to the environments that they were modified for, they out-compete naturally occurring plants and animals. In science, such organisms are termed as invasive species. They are basically organisms with uncontrollable growth of populations up to a degree that already harms organisms and the environment.

Because of the technology used to create genetically modified crops and animals, private companies that produce them do not share their products at a reasonable cost with the public.

BioethicsFor critics, genetic engineering has no resemblance to the natural process of breeding. This is because in the process, a different gene is forced to combine to the genes of an organism.

In addition, they believe that the process is somewhat disrupting the natural way and complexity of life. In addition to this, critics fear the misuse and abuse of biotechnology.

Indeed, genetic engineering will always have two opposite sides. While the possibilities of what science can create are endless, and the harmful effects also are. At present, it is important to know that the real risks and benefits of genetic engineering lie in how science is interpreted and used.

But theres really no doubt that with the rapid advancements in technology, the creation of GM organisms are also increasing.

What do you think? Are GM organisms slowly becoming the future?

13 Important Genetic Engineering Pros And Cons

See more here:
13 Important Genetic Engineering Pros And Cons | Bio Explorer

Read More...

Preventive medicine | Britannica.com

November 20th, 2018 6:43 pm

Preventive medicine, efforts directed toward the prevention of disease, either in the community as a wholean important part of what is broadly termed public healthor in the individual.

Read More on This Topic

therapeutics: Preventive medicine

The rationale for preventive medicine is to identify risk factors in each individual and reduce or eliminate those risks in an attempt to prevent disease. Primary prevention is the preemptive behavior that seeks to avert disease before it developsfor example, vaccinating children against

Hippocrates, the Greek physician of the 5th century bc, classified causes of disease into those concerned with seasons, climates, and external conditions, and those more personal causes such as irregular food, exercise, and habits of the individual. Through the Middle Ages the principles of preventive medicine were ignored, in spite of the scourges of leprosy and plague. With the Renaissance came the new learning that revolutionized the whole content of medicine. Practitioners again observed the relation of the seasons, environmental conditions, and personal contact to the incidence of disease.

Concurrent with the growth of medical knowledge there was an empirical movement of practical prevention. For example, in 1388 there was passed the first sanitary act in England, directed to the removal of nuisances; in 1443 came the first plague order recommending quarantine and cleansing; and in 1518 the first rough attempts at notification of epidemic disease and isolation of the patient were made. The study of mortality statistics was initiated in England in the 17th century. The basis of epidemiology was laid in the mid-17th century. In 1700 a treatise on occupational disorders was published in Italy. An English practitioner in the first half of the 18th century wrote on poisons, on plague and methods of its prevention, and on smallpox, measles, and scurvy. Vaccination was introduced in 1798. The early and middle years of the 19th century were notable for discoveries in the transmission of contagious diseases such as typhus, cholera, typhoid fever, and childbed (puerperal) fever. In the same period increasing attention was given to problems of hygiene and nutrition.

The modern era in preventive medicine opened in the mid-19th century with Louis Pasteurs discovery of the role of living microbes as the cause of infections. Toward the close of the century the principle of insect-borne transmission of disease was established. Serological tests were developed, such as the Widal reaction for typhoid fever (1896) and the Wassermann test for syphilis (1906). An understanding of the principles of immunity led to the development of active immunization to specific diseases. Parallel advances in treatment opened other doors for preventionin diphtheria by antitoxin and in syphilis by arsphenamine. In 1932 the sulfonamide drugs and later the antibiotics including penicillin, streptomycin, chlortetracycline, and chloramphenicol afforded new opportunities of prevention and cure of bacterial diseases.

After 1900 there were many advances in preventive medicine other than those related to infectious diseases. The use of X rays and radioactive substances in the diagnosis and treatment of disease (e.g., tuberculosis and cancer) as well as in fundamental physiological research opened new possibilities. A greater understanding of endocrine functions, with the production of prepared hormone extracts such as insulin, led to preventive measures in certain metabolic diseases. The role of nutrition in health and disease and the isolation of many essential food factors illustrated the importance to health of adequate diet. Other 20th-century advances in preventive medicine included a wider recognition of psychological factors in relation to total health, new surgical techniques, new methods of anesthesia, and genetics research.

View post:
Preventive medicine | Britannica.com

Read More...

How to Boost Your Immune System – Dr. Axe

November 19th, 2018 9:42 am

We are continually exposed to organisms that are inhaled, swallowed or inhabit our skin and mucous membranes. Whether or not these organisms lead to disease is decided by the integrity of our bodys defense mechanisms, or immune system. When our immune system is working properly, we dont even notice it. But when we have an under- or over-active immune system, we are at a greater risk of developing infections and other health conditions.

If you are wondering how to boost your immune system, look no further these 10 antimicrobial, immune-stimulating and antiviral supplements and essential oils can be used at home to improve your health.

The immune system is an interactive network oforgans, cells and proteins that protect the body from viruses and bacteria or any foreign substances. The immune system works to neutralize and remove pathogens like bacteria, viruses, parasites or fungi that enter the body, recognize and neutralize harmful substances from the environment, and fight against the bodys own cells that have changes due to an illness. (1)

The cells of the immune system originate in the bone marrow, then migrate to guard the peripheral tissues, circulating in the blood and in the specialized system of vessels called the lymphatic system.

When our immune system is working properly, we dont even notice it. Its when the performance of our immune system is compromised that we face illness. Underactivity of the immune system results in severe infections and tumors of immunodeficiency, while overactivity results in allergic and autoimmune diseases. (2)

For our bodys natural defenses to run smoothly, the immune system must be able to differentiate between self and non-self cells, organisms and substances. Non-self substances are called antigens, which includes the proteins on the surfaces of bacteria, fungi and viruses. When the cells of the immune system detect the presence of an antigen, the immune system recalls stored memories in order to quickly defend itself against known pathogens.

However, our own cells also have surface proteins, and its important that the immune system does not work against them. Normally, the immune system has already learned at an earlier stage to identify these cells proteins as self, but when it identifies its own body as non-self, this is called an autoimmune reaction. (3)

The amazing thing about the immune system is that its constantly adapting and learning so that the body can fight against bacteria or viruses that change over time. There are two parts of the immune system our innate immune system works as a general defense against pathogens and our adaptive immune system targets very specific pathogens that the body has already has contact with. These two immune systemscomplement each other in any reaction to a pathogen or harmful substance. (4)

Before learning exactly how to boost your immune system, first understand that most immune disorders result from either an excessive immune response or an autoimmune attack. Disorders of the immune system include:

Allergiesare a immune-mediated inflammatory response to normally harmless environmental substances known as allergens, which results in one or more allergic diseases such as asthma, allergic rhinitis, atopic dermatitis and food allergies. When the body overreacts to an allergen, such as dust, mold or pollen, it causes an immune reaction that leads to the development of allergy symptoms.

Allergies and asthma is a growing epidemic, affecting people of all ages, races, genders and socioeconomic statuses. In the U.S., it is estimated that more than 35 million people, mostly children, suffer from asthma symptoms. (5)An immune response to an allergic can be mild, from coughing and a runny nose, to a life-threatening reaction known as anaphylaxis. A person becomes allergic to a substance when the body develops antigens against it and has a reaction upon repeated exposure to that substance.

An immune deficiency disease is when the immune system is missing one or more of its parts, and it reacts too slowly to a threat. Immune deficiency diseases can be caused by medications or illness, or it may be a genetic disorder, which is called primary immunodeficiency. (6)

Some immune deficiency diseases include severe combined immune deficiency, common variable immune deficiency, human immunodeficiency virus/acquired immune deficient syndrome (HIV/AIDS), drug-induced immune deficiency and graft versus host syndrome. All of these conditions are due to a severe impairment of the immune system, which leads to infections that are sometimes life-threatening.

Autoimmune diseases cause your immune system to attack your own bodys cells and tissues in response to an unknown trigger. Autoimmune diseases have registered an alarming increase worldwide since the end of the Second World War, with more than 80 autoimmune disorders and increases in both the incidence and prevalence of these conditions. (7)

Fiftymillion Americans are living with an autoimmune disease today, and for many of them, its hard to get an accurate diagnosis right away. In fact, it often takes about five years to receive a diagnosis because autoimmune disease symptoms are so disparate and vague. Examples of autoimmune diseases include rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis, type 1 diabetes, psoriasis, Graves disease (overactive thyroid), Hashimotos disease (underactive thyroid) and vasculitis.

Treatment for autoimmune diseases typically focus on reducing the immune systems activity, but your first line of defense should be addressing leaky gut and removing foods and factors that damage the gut. Several studies have shown that increased intestinal permeability is associated with several autoimmune diseases, and it appears to be involved in disease pathogenesis. (8)

When searching for how to boost your immune system, look to these 10 herbs, supplements and essential oils.

Many of echinaceas chemical constituents are powerful immune system stimulants that can provide significant therapeutic value. Research shows that one of the most significant echinacea benefits is its effects when used on recurring infections. A 2012 study published in Evidence-Based Complementary and Alternative Medicine found that echinacea showed maximal effects on recurrent infections, and preventive effects increased when participants used echinacea to prevent the common cold. (9)

A 2003 study conducted at the University of Wisconsin Medical School found that echinacea demonstrates significant immunomodulatory activities. After reviewing several dozen human experiments, including a number of blind randomized trials, researchers indicate that echinacea has several benefits, including immunostimulation, especially in the treatment of acute upper respiratory infection. (10)

The berries and flowers of the elder plant have been used as medicine for thousands of years. Even Hippocrates, the father of medicine, understood that this plant was key for how to boost your immune system. He used elderberry because of its wide array of health benefits, including its ability to fight colds, the flu, allergies and inflammation. Several studies indicate that elderberry has the power to boost the immune system, especially because it has proven to help treat the symptoms of the common cold and flu.

A study published in the Journal of International Medical Research found that when elderberry was used within the first 48 hours of onset of symptoms, the extract reduced the duration of the flu, with symptoms being relieved on an average of four days earlier. Plus, the use of rescue medication was significantly less in those receiving elderberry extract compared with placebo. (11)

Dating back to ancient times, silver was a popular remedy to stop the spread of diseases. Silver has historically and extensively been used as a broad-spectrum antimicrobial agent. Research published in the Journal of Alternative and Complementary Medicine suggests that colloidal silver wasable to significantly inhibit the growth the bacteria grown under aerobic and anaerobic conditions. (12)

To experience colloidal silver benefits, it can be used in several ways. How toboost your immune system with this supplement? Simply take one drop of true colloidal silver with internally. It can also be applied to the skin to help heal wounds, sores and infections. Always keep in mind that it should not be used for more than 14 days in a row.

You may come across many warnings about colloidal silver causing an irreversible condition called argyria (when people turn blue); however, this is caused by the misuse of products that are not true colloidal silver, like ionic or silver protein. (13)

Because leaky gut is a major cause of food sensitivities, autoimmune disease and immune imbalance or a weakened immune system, its important to consume probiotic foods and supplements. Probiotics are good bacteria that help you digest nutrients that boost the detoxification of your colon and support your immune system.

Research published in Critical Reviews in Food Science and Nutrition suggests that probiotic organisms may induce different cytokine responses. Supplementation of probiotics in infancy could help prevent immune-mediated diseases in childhood by improving the gut mucosal immune system and increasing the number of immunoglobulin cells and cytokine-producing cells in the intestines. (14)

Astragalusis a plant within the bean and legumes family that has a very long history as an immune system booster and disease fighter. Its root has been used as an adaptogen inTraditional Chinese Medicine for thousands of years. Although astragalus is one of the least studied immune-boosting herbs, there are some preclinical trials that show intriguing immune activity. (15)

A recent review published in the American Journal of Chinese Medicine found that astragalus-based treatments have demonstrated significant improvementof the toxicity induced by drugs such as immunosuppressants and cancer chemotherapeutics. Researchers concluded that astragalus extract has a beneficial effect on the immune system, and it protects the body from gastrointestinal inflammation and cancers. (16)

Ayurvedic medicine has relied ongingers ability for how toboost yourimmune system before recorded history. Its believed that ginger helps to break down the accumulation of toxins in our organs due to its warming effects. Its also known to cleanse the lymphatic system, our network of tissues and organs that help rid the body of toxins, waste and other unwanted materials.

Ginger root and ginger essential oil can treat a wide range of diseases with its immunonutrition and anti-inflammatory responses. Research shows that ginger has antimicrobial potential, which helps in treating infectious diseases. Its also known for its ability to treat inflammatory disorders that are caused by infectious agents such as viruses, bacteria and parasites, as well as physical and chemical agents like heat, acid and cigarette smoke. (17)

7. Ginseng

The ginseng plant, belonging to the Panax genus, can help you to boost your immune system and fight infections. The roots, stems and leaves of ginseng have been used for maintaining immune homeostasis and enhancing resistance to illness or infection. Ginseng improves the performance of your immune system by regulating each type of immune cell, including macrophages, natural killer cells, dendritic cells, T cells and B cells. It also has antimicrobial compounds that work as a defense mechanism against bacterial and viral infections. (18)

A study published in the American Journal of Chinese Medicine found that ginseng extract successfully induced antigenspecific antibody responses when it was administered orally. Antibodies bind to antigens, such as toxins or viruses, and keep them from contacting and harming normal cells of the body. Because of ginsengs ability to play a role in antibody production, it helps the body to fight invading microorganisms or pathogenic antigens. (19)

Vitamin D can modulate the innate and adaptive immune responses and a vitamin D deficiency is associated with increased autoimmunity as well as an increased susceptibility to infection. Research shows that vitamin D works to maintain tolerance and promote protective immunity. There have been multiple cross-sectional studies that associate lower levels of vitamin D with increased infection. (20)

One study conducted at Massachusetts General Hospital included 19,000 participants, and it showed that individuals with lower vitamin D levels were more likely to report a recent upper respiratory tract infection than those with sufficient levels, even after adjusting for variables such as season, age, gender, body mass and race. (21) Sometimes addressing a nutritional deficiency is how to boost your immune system.

Myrrh is a resin, or sap-like substance, that is one of the most widely used essential oils in the world. Historically, myrrh was used to treat hay fever, clean and heal wounds and stop bleeding. Myrrh strengthens the immune system with its antiseptic, antibacterial and antifungal properties. (22)

A 2012 study validated myrrhs enhanced antimicrobial efficacy when used in combination with frankincense oil against a selection of pathogens. Researchers concluded that myrrh oil has anti-infective properties and can help to boost your immune system. (23)

Oregano essential oil is known for its healing and immune-boosting properties. It fights infections naturally due to its antifungal, antibacterial, antiviral and anti-parasite compounds. A 2016 study published in Critical Reviews in Food Science and Nutrition found that the main compounds in oregano that are responsible for its antimicrobial activity include carvacrol and thymol. (24)

Several scientific studies found that oregano oil exhibited antibacterial activity againsta number of bacterial isolates and species, includingB. laterosporus andS. saprophyticus. (25)

I should also stress the importance of incorporating physical activity into your daily and weekly regimen to strengthen your immune system. A 2018 human study published in Aging Cell revealed that high levels of physical activity and exercise improve the immunosenescence (gradual deterioration of the immune system) in older adults aged 55 through 79, compared to those in the same age group who were physically inactive. The study also highlights that physical activity doesnt protect against all of the immunosenescence that occurs. However, the decrease in a persons immune system function and activity can be influenced by decreased physical activity in addition to age. (26)

In the quest for how to boost your immune system, proceed with some caution. If you are using these immune-boosting herbs and essential oils, remember that the products are extremely potent and should not be taken for more than two weeks at a time. Giving yourself a break in between long doses is important.

Also, if you are pregnant, be cautious when using essential oils and reach out to your health care provider before doing so. Any time you are using natural remedies like plant supplements, its a good idea to do it under the care of your doctor or nutritionist.

From the sound of it, you might think leaky gut only affects the digestive system,but in reality it can affect more. Because Leaky Gut is so common, and such an enigma,Im offering a free webinar on all things leaky gut.Click here to learn more about the webinar.

Go here to read the rest:
How to Boost Your Immune System - Dr. Axe

Read More...

Nobel Prize Doctor Yamanaka: Stem Cell Progress ‘Just the …

November 17th, 2018 4:45 am

Professor Shinya Yamanaka of Kyoto University, 55, became more widely known after he was awarded the Nobel Prize in Physiology or Medicine in 2012. Five years before that, however, in November 2007, he announced that he had generated human-induced pluripotent stem cells (iPS cells).

His research on treating illnesses has seen impressive progress, but, according to him, this is just the beginning.

Yamanaka, 55, was born in 1962 in Osaka. He graduated from Kobe University School of Medicine and completed his PhD at Osaka University Graduate School. He became a professor at Kyoto University in 2004 and the director of Center for iPS Cell Research and Application in 2010.

He recently spoke with journalist Juichiro Ito of Sankei Shimbuns Science Department about the future of medical treatment through iPS cell generation.

Its the 10th anniversary of human iPS cell generation.

It sounds like a long time, but it feels like yesterday. I cant believe it has been that long. Maybe time flies faster for me because Im old now, but this is only the beginning.

Research on regenerative medicine and clinical trials of new drugs have begun.

iPS cells have been a catalyst to research that use embryonic stem cells (ES cells). I cannot take all the credit because I wouldnt have made it this far without the efforts of everyone involved. I always remind myself how grateful I should be. Clinical research on age-related macular degeneration (AMD) led by Masayo Takahashi of Riken research institute impressed me the most. By skipping the preclinical development stage consisting of animal testing, she managed to make significant accomplishments in a very short period.

What was the challenge?

The challenge was to build an iPS cell stock which ensures that iPS cells will always be available for regenerative medicine and drug discovery. The process involves providing cells to a specialized company for mass production, which then supplies the cells to medical institutes and pharmaceutical companies. It was a very difficult process because university researchers are a type of people who want to challenge themselves with the unprecedented. Conversely, the production of cells requires the dull repetition of prescribed steps in order to maintain quality. Dealing with this contrast was very difficult.

At first, people pointed out the risks of the cells becoming cancerous.

The early-stage iPS cells couldnt be used for clinical research because of these concerns. However, the production method has evolved and the situation has changed. The risk has not been completely eliminated but is significantly lower, so the cells can now be used for clinical research.

You were awarded the Nobel Prize in Physiology or Medicine in 2012.

It was a great honor. The moment I successfully generated iPS cells, I had the huge responsibility of getting things off the ground, starting with the clinical research. But receiving the prize increased awareness within the general public and those in the industry, and this became a tailwind for my research in many ways. Im very grateful for that, as it also helped Kyoto University collect funds for the Center for iPS Cell Research Application (CiRA).

If you were to compare the current iPS research to a marathon, how many kilometers do you still have to run?

It might be an exaggeration to say that were only at the start line, but I would say weve run no more than 10 kilometers. The real challengethe crucial stagesstarts now, including clinical research and trials of new drugs. Our goal is truly ambitious, as we are taking unprecedented steps while prioritizing the safety of the patients. Im assuming that the challenges that lie ahead will be incomparable to anything Ive faced in the past.

What is the goal of the research?

I estimate that several treatments using regenerative medicine and new drugs will be developed, authorized, and covered by insurance around 2030. However, some treatments may take longer to develop, and unforeseeable challenges may come up. We cannot simply visualize our goal. Its more important to take slow but sure steps towards it.

What are the problems regarding cost and time?

In regenerative medicine, it takes a lot of money and time to custom-make iPS cells from the patients cells. Instead, we create iPS cells from dozens of people with an immunological type that has a lower risk of rejection in Japanese people. However, the great hurdle is how to maintain ample stock of these cells.

What percentage of the population do the cells cover?

Currently, we provide iPS cells of three immunological types. They will not trigger a rejection response in 30% of the Japanese population. It shouldnt be long until we reach 50%. However, we are concerned that increasing the types of iPS cells available will inevitably lead to a higher production cost, which means the cells might become difficult to access for medical treatment. The more cell types there are, the more production facilities the manufacturing companies will require, and more money and time will be necessary for safety checks. Alternatively, it might be more efficient to use just one type of cell which covers the greatest percentage of the population, and to provide immunosuppressant drugs to those that have a rejection response.

What is your plan for the future?

If a huge amount of national expenditure is invested into creating more types of cells but the cells end up being unusable, it would be a considerable waste. Until now, we have been aiming to reach 80% of the population by 2022, but we are now reevaluating our goal. This is a problem we cannot solve by ourselves. We want the government to consider implementing a system that ensures safety checks while containing the costs.

Clinical research and trials have started to make the cells useful for patients.

We have only just reached the start line. For the next 10 or 20 years, it will be more like the patients contributing to the research at their own risk, rather than us contributing to them. I need to start making true contributions to the patients as soon as possible. People enduring incurable diseases have written numerous letters to us about their wish to be cured using iPS cells. I am fully aware of their desperate situation and working hard towards making their wish come true.

Ikumi Yamamoto, 19, from Akashi in Hyogo Prefecture, who suffered from fibrodysplasia ossificans progressiva (FOP), underwent the first ever treatment for incurable diseases using iPS cells in October.

She came to see me when she was a sixth grade elementary student, and told me that she wanted me to generate iPS cells using her cells to further my research. Such encounters have become a driving force in my research. I think of iPS cells as the patients themselves. When I conduct experiments, the face of the patients who provided the original cells always come to my mind, which makes me more determined to find a cure for them.

Hideo Shinozawa, an honorary professor of Gakushuin University, died in October after a long battle with amyotrophic lateral sclerosis (ALS).

The professor sent me a letter to tell me how much he wanted me to develop a treatment. The letter is displayed in my laboratory so that I am always reminded of his strong desire while I go about my work. ALS is one of the diseases I want to defeat the most. I want to find a cure as soon as possible, but Im unfortunately not at that stage yet.

What kind of attitude should medical researchers have?

As a researcher, you must first conduct good research and write research papers. While doing this, the researcher must have a strong determination to help the patients no matter how long it takes. Being a researcher is difficult, but thinking about the patients keeps us going.

Do you still run marathons as a hobby?

During my lunch breaks on weekdays, I run for 30 minutes along Kamo River and near Nanzen-ji Temple, which are located near the research institute. On weekends, I run around Osaka Castle near my house and around the Tokyo Imperial Palace when Im in Tokyo for work. Running helps me refresh my tired brain, just like the initialization process involved in iPS cell generation.

I managed to run a personal best of 3 hours 27 minutes and 42 seconds at the Kyoto Marathon in February. I will run the Osaka Marathon in November. The Beppu-ita Marathon, which I will be running next February, will be used to select representatives for the 2020 Tokyo Olympics, so I might have a chance. Perhaps well see a miracle (laughs).

The Rapid Progress of Clinical Research and the Challenge of Efficient Cell Generation

iPS cell research has garnered attention as people put their hopes on regenerative medicine to transplant new cells and tissue to injured or ill patients. Research institute Riken succeeded in the first ever transplant in 2014 using iPS cells, setting a major landmark in this field.

The transplant involved creating retinal cells using iPS cells generated from a patient with age-related macular degeneration, a serious eye condition. In March 2017, the transplant of retinal cells from a donor using stock iPS cells succeeded, totalling five successful transplants.

For 2018, clinical research on spinal cord injury and heart failure are being scheduled by Keio University and Osaka University, respectively. Yokohama City University also plans to conduct clinical research on liver failure in 2019 onwards, making Japan the trail blazer in this area. However, most of this research is on cell transplantation; the possibility of transplanting complex organs is still not within reach.

iPS cells are also used to research the pathogenesis of diseases and drug discovery. This is because the mechanisms of diseases can be revealed by creating iPS cells from patients with incurable diseases and replicating the disease outside of the body. Recently, the mechanisms of diseases that affect the motor system, such as Parkinsons disease and ALS, have become better understood.

The mass production of the patients cells for testing makes the development of new drugs more efficient. Potential treatment for FOP, a disease that turns muscle into bone, has been discovered through this method. The method is also being used for ALS and Alzheimers disease. However, this method has not met early expectations that it would be available for clinical application sooner than regenerative medicine.

The big challenge is efficient cell generation. It takes several months to create iPS cells and cells of the affected area. Research on implementing artificial intelligence for efficiency and improvement of cell generation methods is intensifying.

Juichiro Ito is a staff writer of the Sankei Shimbun Science news department.

See the rest here:
Nobel Prize Doctor Yamanaka: Stem Cell Progress 'Just the ...

Read More...

IEEE-NANOMED 2016 The 10th IEEE International Conference …

November 17th, 2018 4:44 am

Holiday Inn Macao Cotai Central Sands Cotai Central, Cotai Strip, Taipa, Macau SAR, China

Program Timetable (PDF version) is available. (FINAL, updated on Oct 26)

Registration Time:

IEEE-NANOMED is one of the premier annual events organized by the IEEE Nanotechnology Council to bring together physicians, scientists and engineers alike from all over the world and every sector of academy and industry, working at advancement of basic and clinical research in medical and biological sciences using nano/molecular and engineering methods. IEEE-NANOMED is the conference where practitioners will see nano/molecular medicine and engineering at work in both their own and related fields, from essential and advanced scientific and engineering research and theory to translational and clinical research.

Conference Theme:

Authors are also invited to submit results to a special issue of the journal Micromachines (impact factor 1.295), on the topic of Microdevices and Microsystems for Cell Manipulation. More information on the special issue and paper submission can be found here:http://www.mdpi.com/journal/micromachines/special_issues/cell_manipulation

Authors are also invited to submit results to a special issue of the journal Micromachines (impact factor 1.295), on the topic of MEMS/NEMS for Biomedical Imaging and Sensing. More information on the special issue and paper submission can be found here:http://www.mdpi.com/journal/micromachines/special_issues/MEMS_biomedical_imaging_sensing

Originally posted here:
IEEE-NANOMED 2016 The 10th IEEE International Conference ...

Read More...

LASIK – Wikipedia

November 16th, 2018 2:48 pm

For the drug used for hypertension, see Lasix. For the Slovakian footballer, see Richard Lsik.

LASIK or Lasik (laser-assisted in situ keratomileusis), commonly referred to as laser eye surgery or laser vision correction, is a type of refractive surgery for the correction of myopia, hyperopia, and astigmatism.[1] The LASIK surgery is performed by an ophthalmologist who uses a laser or microkeratome to reshape the eye's cornea in order to improve visual acuity.[2] For most people, LASIK provides a long-lasting alternative to eyeglasses or contact lenses.[3]

LASIK is most similar to another surgical corrective procedure, photorefractive keratectomy (PRK), and LASEK. All represent advances over radial keratotomy in the surgical treatment of refractive errors of vision. For patients with moderate to high myopia or thin corneas which cannot be treated with LASIK and PRK, the phakic intraocular lens is an alternative.[4][5] As of 2018, nearly 10 million LASIK procedures had been performed in the United States[1][6] and, as of 2016, over 40 million have been performed worldwide since 1991.[7][8]However, the procedure seems to be a declining option for many in the United States, dropping more than 50 percent, from about 1.5 million surgeries in 2007 to 604,000 in 2015, according to the eye care data source Market Scope.[9]

In 2006, the British National Health Service's National Institute for Health and Clinical Excellence (NICE) considered evidence of the effectiveness and the potential risks of the laser surgery stating "current evidence suggests that photorefractive (laser) surgery for the correction of refractive errors is safe and efficacious for use in appropriately selected patients. Clinicians undertaking photorefractive (laser) surgery for the correction of refractive errors should ensure that patients understand the benefits and potential risks of the procedure. Risks include failure to achieve the expected improvement in unaided vision, development of new visual disturbances, corneal infection and flap complications. These risks should be weighed against those of wearing spectacles or contact lenses."[10] The FDA reports "The safety and effectiveness of refractive procedures has not been determined in patients with some diseases."[11]

Surveys of LASIK surgery find rates of patient satisfaction between 92 and 98 percent.[12][13][14]In March 2008, the American Society of Cataract and Refractive Surgery published a patient satisfaction meta-analysis of over 3,000 peer-reviewed articles from international clinical journals. Data from the prior 10 years revealed a 95.4 percent patient satisfaction rate among LASIK patients.[15]

Some people with poor outcomes from LASIK surgical procedures report a significantly reduced quality of life because of vision problems or physical pain associated with the surgery.[1] A small percentage of patients may need to have another surgery because their condition is over-corrected or under-corrected. Some patients need to wear contact lenses or glasses even after treatment.[16]

The most common reason for dissatisfaction in LASIK patients is chronic severe dry eye. Independent research indicates 95% of patients experience dry eye in the initial post-operative period. This number has been reported to up to 60% after one month. Symptoms begin to improve in the vast majority of patients in the 6 to 12 months following the surgery.[17] However, 30% of post-LASIK referrals to tertiary ophthalmology care centers have been shown to be due to chronic dry eye.[18][19]

Morris Waxler, a former FDA official who was involved in the approval of LASIK, has subsequently criticized its widespread use. In 2010, Waxler made media appearances and claimed that the procedure had a failure rate greater than 50%. The FDA responded that Waxler's information was "filled with false statements, incorrect citations" and "mischaracterization of results".[20]

A 2016 JAMA study indicates that the prevalence of complications from LASIK are higher than indicated, with the study indicating many patients wind up with glare, halos or other visual symptoms.[21]

A type of LASIK, known as presbyLasik, may be used in presbyopia. Results are, however, more variable and some people have a decrease in visual acuity.[22]

Higher-order aberrations are visual problems that require special testing for diagnosis and are not corrected with normal spectacles (eyeglasses). These aberrations include 'starbursts', 'ghosting', 'halos' and others.[23][1] Some patients describe these symptoms post-operatively and associate them with the LASIK technique including the formation of the flap and the tissue ablation.[24]

The advancement of the LASIK technology has reduced the risk of clinically significant visual impairment after surgery.[citation needed] There is a correlation between pupil size and aberrations. This correlation may be the result of irregularity in the corneal tissue between the untouched part of the cornea and the reshaped part. Daytime post-LASIK vision is optimal, since the pupil size is smaller than the LASIK flap. However, at night, the pupil may dilate such that light passes through the edge of the LASIK flap, which gives rise to aberrations. LASIK and PRK may induce spherical aberration if the laser under-corrects as it moves outward from the centre of the treatment zone, especially when major corrections are made.[citation needed]

Others propose that higher-order aberrations are present preoperatively.[25] They can be measured in micrometers (m) whereas the smallest laser beam size approved by the FDA is about 1000 times larger, at 0.65mm. In situ keratomileusis effected at a later age increases the incidence of corneal higher-order wavefront aberrations.[26][27] These factors demonstrate the importance of careful patient selection for LASIK treatment.

95% of patients report dry eye symptoms after LASIK[28][1] Although it is usually temporary, it can develop into chronic and severe dry eye syndrome. Quality of life can be severely affected by dry eye syndrome.[29]

Underlying conditions with dry eye such as Sjgren's syndrome are considered contraindications to Lasik.[30]

Treatments include artificial tears, prescription tears and punctal occlusion. Punctal occlusion is accomplished by placing a collagen or silicone plug in the tear duct, which normally drains fluid from the eye. Some patients complain of ongoing dry eye symptoms despite such treatments and dry eye symptoms may be permanent.[31]

Some post-LASIK patients see halos and starbursts around bright lights at night.[1] At night, the pupil may dilate to be larger than the flap leading to the edge of the flap or stromal changes causing visual distortion of light that does not occur during the day when the pupil is smaller. The eyes can be examined for large pupils pre-operatively and the risk of this symptom assessed.

Complications due to LASIK have been classified as those that occur due to preoperative, intraoperative, early postoperative, or late postoperative sources:[32] According to the UK National Health Service complications occur in fewer than 5% of cases.[28]

In October 2009, the FDA, the National Eye Institute (NEI), and the Department of Defense (DoD) launched the LASIK Quality of Life Collaboration Project (LQOLCP) to help better understand the potential risk of severe problems that can result from LASIK[49] in response to widespread reports of problems experienced by patients after LASIK laser eye surgery.[50] This project examined patient-reported outcomes with LASIK (PROWL). The project consisted of three phases: pilot phase, phase I, phase II (PROWL-1) and phase III (PROWL-2).[51] The last two phases were completed in 2014.

The results of the LASIK Quality of Life Study were published in October, 2014.[49]

The FDA's director of the Division of Ophthalmic Devices, said about the LASIK study "Given the large number of patients undergoing LASIK annually, dissatisfaction and disabling symptoms may occur in a significant number of patients".[52] Also in 2014, FDA published an article highlighting the risks and a list of factors and conditions individuals should consider when choosing a doctor for their refractive surgery.[53]

The planning and analysis of corneal reshaping techniques such as LASIK have been standardized by the American National Standards Institute, an approach based on the Alpins method of astigmatism analysis. The FDA website on LASIK states,

The procedure involves creating a thin flap on the eye, folding it to enable remodeling of the tissue beneath with a laser and repositioning the flap.

Patients wearing soft contact lenses are instructed to stop wearing them 5 to 21 days before surgery. One industry body recommends that patients wearing hard contact lenses should stop wearing them for a minimum of six weeks plus another six weeks for every three years the hard contacts have been worn.The cornea is avascular because it must be transparent to function normally. Its cells absorb oxygen from the tear film. Thus, low-oxygen-permeable contact lenses reduce the cornea's oxygen absorption, sometimes resulting in corneal neovascularizationthe growth of blood vessels into the cornea. This causes a slight lengthening of inflammation duration and healing time and some pain during surgery, because of greater bleeding.Although some contact lenses (notably modern RGP and soft silicone hydrogel lenses) are made of materials with greater oxygen permeability that help reduce the risk of corneal neovascularization, patients considering LASIK are warned to avoid over-wearing their contact lenses.

In the United States, the FDA has approved LASIK for age 18 or 22 and over because the vision has to stabilize. More importantly the patient's eye prescription should be stable for at least one year prior to surgery.The patient may be examined with pupillary dilation and education given prior to the procedure. Before the surgery, the patient's corneas are examined with a pachymeter to determine their thickness, and with a topographer, or corneal topography machine,[2] to measure their surface contour. Using low-power lasers, a topographer creates a topographic map of the cornea. The procedure is contraindicated if the topographer finds difficulties such as keratoconus[2] The preparatory process also detects astigmatism and other irregularities in the shape of the cornea. Using this information, the surgeon calculates the amount and the location of corneal tissue to be removed. The patient is prescribed and self-administers an antibiotic beforehand to minimize the risk of infection after the procedure and is sometimes offered a short acting oral sedative medication as a pre-medication. Prior to the procedure, anaesthetic eye drops are instilled. Factors that may rule out LASIK for some patients include large pupils, thin corneas and extremely dry eyes.[55]

A soft corneal suction ring is applied to the eye, holding the eye in place. This step in the procedure can sometimes cause small blood vessels to burst, resulting in bleeding or subconjunctival hemorrhage into the white (sclera) of the eye, a harmless side effect that resolves within several weeks. Increased suction causes a transient dimming of vision in the treated eye. Once the eye is immobilized, a flap is created by cutting through the corneal epithelium and Bowman's layer. This process is achieved with a mechanical microkeratome using a metal blade, or a femtosecond laser that creates a series of tiny closely arranged bubbles within the cornea. A hinge is left at one end of this flap. The flap is folded back, revealing the stroma, the middle section of the cornea. The process of lifting and folding back the flap can sometimes be uncomfortable.

The second step of the procedure uses an excimer laser (193nm) to remodel the corneal stroma. The laser vaporizes the tissue in a finely controlled manner without damaging the adjacent stroma. No burning with heat or actual cutting is required to ablate the tissue. The layers of tissue removed are tens of micrometers thick.

Performing the laser ablation in the deeper corneal stroma provides for more rapid visual recovery and less pain than the earlier technique, photorefractive keratectomy (PRK).[56]

During the second step, the patient's vision becomes blurry, once the flap is lifted. They will be able to see only white light surrounding the orange light of the laser, which can lead to mild disorientation. The excimer laser uses an eye tracking system that follows the patient's eye position up to 4,000 times per second, redirecting laser pulses for precise placement within the treatment zone. Typical pulses are around 1 millijoule (mJ) of pulse energy in 10 to 20 nanoseconds.[57]

After the laser has reshaped the stromal layer, the LASIK flap is carefully repositioned over the treatment area by the surgeon and checked for the presence of air bubbles, debris, and proper fit on the eye. The flap remains in position by natural adhesion until healing is completed.

Patients are usually given a course of antibiotic and anti-inflammatory eye drops. These are continued in the weeks following surgery. Patients are told to rest and are given dark eyeglasses to protect their eyes from bright lights and occasionally protective goggles to prevent rubbing of the eyes when asleep and to reduce dry eyes. They also are required to moisturize the eyes with preservative-free tears and follow directions for prescription drops. Occasionally after the procedure a bandage contact lens is placed to aid the healing, and typically removed after 34 days. Patients should be adequately informed by their surgeons of the importance of proper post-operative care to minimize the risk of complications.[58]

Wavefront-guided LASIK is a variation of LASIK surgery in which, rather than applying a simple correction of only long/short-sightedness and astigmatism (only lower order aberrations as in traditional LASIK), an ophthalmologist applies a spatially varying correction, guiding the computer-controlled excimer laser with measurements from a wavefront sensor. The goal is to achieve a more optically perfect eye, though the final result still depends on the physician's success at predicting changes that occur during healing and other factors that may have to do with the regularity/irregularity of the cornea and the axis of any residual astigmatism. Another important factor is whether the excimer laser can correctly register eye position in 3 dimensions, and to track the eye in all the possible directions of eye movement. If a wavefront guided treatment is performed with less than perfect registration and tracking, pre-existing aberrations can be worsened. In older patients, scattering from microscopic particles (cataract or incipient cataract) may play a role that outweighs any benefit from wavefront correction. Therefore, patients expecting so-called "super vision" from such procedures may be disappointed.[59][60][61][62]

When treating a patient with preexisting astigmatism, most wavefront-guided LASIK lasers are designed to treat regular astigmatism as determined externally by corneal topography. In patients who have an element of internally induced astigmatism, therefore, the wavefront-guided astigmatism correction may leave regular astigmatism behind (a cross-cylinder effect). If the patient has preexisting irregular astigmatism, wavefront-guided approaches may leave both regular and irregular astigmatism behind. This can result in less-than-optimal visual acuity compared with a wavefront-guided approach combined with vector planning, as shown in a 2008 study.[63] Thus, vector planning offers a better alignment between corneal astigmatism and laser treatment, and leaves less regular astigmatism behind on the cornea, which is advantageous whether irregular astigmatism coexists or not.

The "leftover" astigmatism after a purely surface-guided laser correction can be calculated beforehand, and is called ocular residual astigmatism (ORA). ORA is a calculation of astigmatism due to the noncorneal surface (internal) optics. The purely refraction-based approach represented by wavefront analysis actually conflicts with corneal surgical experience developed over many years.[62]

The pathway to "super vision" thus may require a more customized approach to corneal astigmatism than is usually attempted, and any remaining astigmatism ought to be regular (as opposed to irregular), which are both fundamental principles of vector planning overlooked by a purely wavefront-guided treatment plan.[62] This was confirmed by the 2008 study mentioned above, which found a greater reduction in corneal astigmatism and better visual outcomes under mesopic conditions using wavefront technology combined with vector analysis than using wavefront technology alone, and also found equivalent higher-order aberrations (see below).[63] Vector planning also proved advantageous in patients with keratoconus.[64]

No good data can be found that compare the percentage of LASIK procedures that employ wavefront guidance versus the percentage that do not, nor the percentage of refractive surgeons who have a preference one way or the other. Wavefront technology continues to be positioned as an "advance" in LASIK with putative advantages;[65][66][67][68] however, it is clear that not all LASIK procedures are performed with wavefront guidance.[69]

Still, surgeons claim patients are generally more satisfied with this technique than with previous methods, particularly regarding lowered incidence of "halos," the visual artifact caused by spherical aberration induced in the eye by earlier methods. A meta-analysis of eight trials showed a lower incidence of these higher order aberrations in patients who had wavefront-guided LASIK compared to non-wavefront-guided LASIK.[70] Based on their experience, the United States Air Force has described WFG-Lasik as giving "superior vision results".[71]

Topography-assisted LASIK is intended to be an advancement in precision and reduce night vision side effects. The first topography-assisted device received FDA approval September 13, 2013.[72][73]

In the 1950s, the microkeratome and keratomileusis technique were developed in Bogot, Colombia, by the Spanish ophthalmologist Jose Barraquer. In his clinic, he would cut thin (one hundredth of a mm thick) flaps in the cornea to alter its shape. Barraquer also investigated how much of the cornea had to be left unaltered in order to provide stable long-term results.[74] This work was followed by that of the Russian scientist, Svyatoslav Fyodorov, who developed radial keratotomy (RK) in the 1970s and designed the first posterior chamber implantable contact lenses (phakic intraocular lens) in the 1980s.

In 1980, Rangaswamy Srinivasan, at the IBM Research laboratory, discovered that an ultraviolet excimer laser could etch living tissue, with precision and with no thermal damage to the surrounding area. He named the phenomenon "ablative photo-decomposition" (APD).[75]Five years later, in 1985, Steven Trokel at the Edward S. Harkness Eye Institute, Columbia University in New York City, published his work using the excimer laser in radial keratotomy. He wrote,

Together with his colleagues, Charles Munnerlyn and Terry Clapham, Trokel founded VISX USA inc.[77] Marguerite B. MacDonald MD performed the first human VISX refractive laser eye surgery in 1989.[78]

A number of patents have been issued for several techniques related to LASIK. Stuart I. Brown and Josef F. Bille filed a patent on surgical lasers in 1988.[79] Samuel E. Blum, Rangaswamy Srinivasan and James Wynne filed a patent application on the ultraviolet excimer laser, in 1982, issued in 1988.[80] In 1989, Gholam A. Peyman was granted a US patent for using an excimer laser to modify corneal curvature.[81] It was,

The patents related to so-called broad-beam LASIK and PRK technologies were granted to US companies including Visx and Summit during 1990-1995 based on the fundamental US patent issued to IBM (1983) which claimed the use of UV laser for the ablation of organic tissues.[80]

The LASIK technique was implemented in the U.S. after its successful application elsewhere. The Food and Drug Administration (FDA) commenced a trial of the excimer laser in 1989. The first enterprise to receive FDA approval to use an excimer laser for photo-refractive keratectomy was Summit Technology (founder and CEO, Dr. David Muller).[82]In 1992, under the direction of the FDA, Greek ophthalmologist Ioannis Pallikaris introduced LASIK to ten VISX centres. In 1998, the "Kremer Excimer Laser", serial number KEA 940202, received FDA approval for its singular use for performing LASIK.[83] Subsequently, Summit Technology was the first company to receive FDA approval to mass manufacture and distribute excimer lasers. VISX and other companies followed.[83]

Pallikaris suggested a flap of cornea could be raised by microkeratome prior to the performing of PRK with the excimer laser. The addition of a flap to PRK became known as LASIK.

Since 1991, there have been further developments such as faster lasers; larger spot areas; bladeless flap incisions; intraoperative corneal pachymetry; and "wavefront-optimized" and "wavefront-guided" techniques. The goal of refractive surgery is to avoid permanently weakening the cornea with incisions and to deliver less energy to the surrounding tissues.

A systematic review that compared PRK and LASIK concluded that LASIK has shorter recovery time and less pain.[89] The two techniques after a period of one year have similar results.[89]

A 2017 systematic review found uncertainty in visual acuity, but found that in one study, those receiving PRK were less likely to achieve a refractive error, and were less likely to have an over-correction than compared to LASIK.[90]

Read more:
LASIK - Wikipedia

Read More...

Gene Therapy – Sickle Cell Anemia News

November 16th, 2018 2:46 pm

Gene therapy is an experimental technique that aims to treat genetic diseases by altering a disease-causing gene or introducing a healthy copy of a mutated gene to the body. The U.S. Food and Drug Administrationapprovedthe first gene therapy for an inherited disease a genetic form of blindness in December 2017.

Sickle cell anemia is caused by a mutation in the HBB gene which provides the instructions to make part of hemoglobin, the protein in red blood cells that carries oxygen.

Researchers are working on two different strategies to treat sickle cell anemia with gene therapy. Both of these strategies involve genetically altering the patients own hematopoietic stem cells. These are cells in the bone marrow that divide and specialize to produce different types of blood cells, including the red blood cells.

One strategy is to remove some of the patients hematopoietic stem cells, replace the mutated HBB gene in these cells with a healthy copy of the gene, and then transplant those cells back into the patient. The healthy copy of the gene is delivered to the cells using a modified, harmless virus. These genetically corrected cells will then hopefully repopulate the bone marrow and produce healthy, rather than sickled, red blood cells.

The other strategy is to genetically alter another gene in the patients hematopoietic stem cells so they boost production of fetal hemoglobin a form of hemoglobin produced by babies from about seven months before birth to about six months after birth. This type of hemoglobin represses sickling of cells in patients with sickle cell anemia, but most people only produce a tiny amount of it after infancy. Researchers aim to increase production of fetal hemoglobin in stem cells by using a highly specific enzyme to cut the cells DNA in the section containing one of the genes that suppress production of fetal hemoglobin. When the cell repairs its DNA, the gene no longer works and more fetal hemoglobin is produced.

Gene therapy offers an advantage over bone marrow transplant, in that complications associated with a bone marrow donation now the only cure for the disease such as finding the right match are not a concern.

Twelve clinical trials studying gene therapy to treat sickle cell anemia are now ongoing. Nine of the 12 are currently recruiting participants.

Four trials (NCT02186418, NCT03282656, NCT02247843, NCT02140554) are testing the efficacy and safety of gene therapy to replace the mutated HBB gene with a healthy HBB gene. These Phase 2 trials are recruiting both children and adults in the United States and Jamaica.

Three trials (NCT02193191, NCT02989701, NCT03226691) are investigating the use ofMozobil (plerixafor) in patients with sickle cell anemia to increase the production of stem cells to be used for gene therapy. This medication is already approved to treat certain types of cancer. All three are recruiting U.S. participants.

One trial (NCT00669305) is recruiting sickle cell anemia patients in Tennessee to donate bone marrow to be used in laboratory research to develop gene therapy techniques.

The final study(NCT00012545) is examining the best way to collect, process and store umbilical cord blood from babies with and without sickle cell anemia. Cord blood contains abundant stem cells that could be used in developing gene therapy for sickle cell anemia. This trial is open to pregnant women in Maryland both those who risk having an infant with sickle cell anemia, and those who do not.

One clinical trial (NCT02151526) conducted in France is still active but no longer recruiting participants. It is investigating the efficacy of gene therapy in seven patients. For the trial, a gene producing a therapeutic hemoglobin that functions similarly to fetal hemoglobin is introduced into the patients stem cells. A case studyfrom one of the seven was published in March 2017; it showed that the approach was safe and could be an effective treatment option for sickle cell anemia.

***

Sickle Cell Anemia News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

See the original post:
Gene Therapy - Sickle Cell Anemia News

Read More...

Pros and Cons of Stem Cell Research – The Balance

November 16th, 2018 12:47 am

Debates over the ethics of embryonic stem cell research have divided scientists, politicians, and religious groups for years. However, promising developments in other areas of stem cell research have led to solutions that help bypass these ethical barriers and win more support from those against embryonic stem cell research; the newer methods don't require the destruction of blastocysts.

In 1998, the first published research paper on the topic reported that stem cells could be taken from human embryos. Subsequent research led to the ability to maintain undifferentiated stem cell lines (pluripotent cells) and techniques for differentiating them into cells specific to various tissues and organs.

The debates over the ethics of stem cell research began almost immediately in 1999, despite reports that stem cells cannot grow into complete organisms.

In 20002001, governments worldwide were beginning to draft proposals and guidelines to control stem cell research and the handling of embryonic tissues and reach universal policies. The Canadian Institutes of Health Research (CIHR) drafted a list of recommendations for stem cell research in 2001. In the U.S., the Clinton administration drafted guidelines for stem cell research in 2000. Australia, Germany, the United Kingdom, and other countries followed suit and formulated their own policies.

Debates over the ethics of studying embryonic stem cells continued for nearly a decade until the use of adult-derived stem cellsknown as induced pluripotent stem cells (IPSCs)became more prevalent and alleviated those concerns.

In the U.S. since 2011, federal funds can be used to study embryonic stem cells, but such funding cannot be used to destroy an embryo.

The excitement about stem cell research is primarily due to the medical benefits in areas ofregenerative medicineand therapeutic cloning. Stem cells provide huge potential for finding treatments and cures to a vast array of medical issues:

Stem cell research presents problems like any form of research, but most opposition to stem cell research is philosophical and theological, focusing on questions of whether we should be taking science this far:

Use of adult-derived stem cellsknown as induced pluripotent stem cells (IPSCs)from blood, cord blood, skin, and other tissues has been demonstrated as effective in treating different diseases in animal models. Umbilical cord-derived stem cells obtained from the cord blood also have been isolated and used for various experimental treatments. Another option is uniparental stem cells. Although these cell lines are shorter-lived than embryonic cell lines, uniparental stem cells hold vast potential if enough research money can be directed that way: pro-life advocates do not technically consider them individual living beings.

Two recent developments from stem cell research involve the heart and the blood it pumps. In 2016, researchers in Scotland began working on the possibility of generating red blood cells from stem cells in order to create a large supply of blood for transfusions. A few years earlier, researchers in England began working on polymers derived from bacteria that can be used to repair damaged heart tissue.

See the rest here:
Pros and Cons of Stem Cell Research - The Balance

Read More...

Stem Cell Tourism: Caveat Emptor – Neurologist in Orange …

November 16th, 2018 12:46 am

Posted December 15, 2015 by Jack Florin

Stem cell pseudomedicine is on the rise, becoming highly profitable as patients and families are desperate for a cure for devastating and incurable neurological diseases, such as amyotrophic lateral sclerosis and multiple sclerosis. Treatment with cellular therapy usually costs between $15,000 and $20,000, is not covered by insurance, and is more widely available overseas than in the US, explaining the concept of stem cell tourism. Desperate patients will overlook the lack of rigorously tested scientific evidence and cling to anything, especially patient testimonials found on stem cell tourism web sites. One clinic does biobanking of placental cells in pregnant women with MS. The costs are very high to maintain cell viability with the hope of using them in the future for MS therapy. Other companies tout the concept that patients with MS or ALS can biobank their own skin or placental cells to generate off-the-shelf stem cells to be injected back into the patients in the distant future when the procedures are proven beneficial in clinical trials.

Many clinics advertise with state-of-the-art web sites, on which celebrities and even physicians give flowery testimonials. Often, they state they are conducting an observational cohort study, making the procedures sound official and allowing them to register their study with the government so that it can be found at the generally trusted web site ClinicalTrials.gov.

Physicians, in counseling their patients, must balance patient autonomy with physician beneficence. A hurdle in counseling patients is that the public has a lack of trust in the FDA and a perception that the FDA does not have the best interests of the patient in mind and stalls the development or approval of new therapies. Conspiratorial views are difficult to overcome.

There are real dangers. A child with a rare disease termed ataxia telangiectasia traveled to Russia and received injections into the spinal fluid of neural stem cells and later developed a brain tumor originating from those cells. Two pediatric patients in Germany died because of intracranial bleeding related to injections in a stem cell clinic. A patient in Thailand received stem cell injections directly into her kidney for lupus nephritis. This resulted in a kidney tumor. A clinic in China injected stem cells directly into the spinal cords of hundreds of patients with spinal cord injuries and ALS. There was no benefit, and there were alarming safety issues.

All stem cell therapies are not bogus. There are now several types of stem cells being studied for MS and ALS in reputable medical centers. Stem cell therapies for MS have been done for many years. They can help patients with fulminant MS but do not result in a cure.

Buyer beware.

See JAMA Neurology, November 2015, page 1342.

Excerpt from:
Stem Cell Tourism: Caveat Emptor - Neurologist in Orange ...

Read More...

Stem Cell Chicago | Stem Cell Therapy for Kidney Failure

November 16th, 2018 12:45 am

15 Aug Stem Cell Therapy for Kidney Failure

As Type-2 diabetes and high blood pressure continue to plague the world, the demand for kidney transplants is increasing by the day. Owing to a shortage of organ donors to meet this requirement, stem cell therapies emerge as a hope to cure thousands of patients as an alternative treatment.

Our kidneys are designed to prevent toxins build up in our bodies. Kidneys help remove a lot of waste, cleansing our bodies from within so that no harmful toxins and chemicals destroy our vital organs. Our kidneys also produce hormones to control other body functions.

When more than a third of your kidney function is impaired, chronic kidney disease begins to take place. Other diseases such as diabetes also contribute to worsening this condition. When left untreated, chronic kidney disease gradually worsens and may result in kidney failure in some cases.

When this happens, patients have to rely on a kidney transplant and dialysis to stay alive and perform day to day activities.

Stem cells possess the unique capacity to self-renew if they are provided the right environment. Therefore, stem cells are used to replace or repair damaged tissues. This is why stem cells can be of significant help in treating kidney failure.

There has been a lot of research to study the effects of stem cells to regenerate a damaged kidney and re-establish its lost function. The past few decades have shown a substantial improvement in identifying how stem cells can play their role in treating several medical conditions such as kidney failure.

Researchers have concentrated on focusing on how human induced pluripotent stem cells and bone marrow mesenchymal stem cells (MSCs) can deliver maximum results in restoring kidney function.

Mesenchymal stem cells regenerate into several different types of stem cells. These cells can be incorporated into the renal tubular cells and develop into mesangial cells. Moreover, these cells revitalize the kidneys stem cells and support the survival of renal cells by discharging growth stimulants, to initiate the natural recovery process.

Cases in which stem cells are taken from bone marrow and fat to treat patients suffering from chronic nephritis (resulting in kidney failure) have revealed positive outcomes.

The treatment involves delivering the mesenchymal stem cells and the bone marrow directly into the kidneys to begin repairing the damage on their own.

In the same way, stem cell therapy is also useful in treating complicated conditions such as multiple myeloma, (which also leads to a kidney failure), by transplanting bone marrow stem cells.

Although we are yet to declare the stem cell therapy to be the ultimate treatment for kidney failure, it is definitely useful in slowing down and sometimes suspending the progression of CKD.

Modern stem cells therapies that are currently available utilize stem cells to repair and regenerate damaged renal cells and improve the function of the kidney to slow down the diseases progression.

View post:
Stem Cell Chicago | Stem Cell Therapy for Kidney Failure

Read More...

Integrative Medicine | The Everett Clinic

November 15th, 2018 1:46 am

What is integrative medicine?

Integrative medicine is a patient-centered approach that addresses the biological, psychological, social and spiritual aspects of health and illness. It is a very personalized approach that takes into consideration your unique conditions, needs, and circumstances. Integrative medicine utilizes multiple evidenced based disciplines to help prevent and heal illness and disease and help patients move toward optimal health.

It is based on a partnership between provider and patient, emphasizes respect for the human capacity for healing and utilizes more natural, less invasive therapies when appropriate.

Integrative medicine can be effective at treating chronic disease comprehensively and works with you to prevent disease development. By deeply examining your unique qualities, family history, lifestyle, social structure, and medical status, an individualized care plan is developed. Integrative medicine providers partner with you as well as your primary care provider (PCP) to help provide effective solutions.

Integrative medicine combines all forms of medicine beyond the traditional Western modelso a treatment plan may include diet modifications, nutritional or herbal supplements or recommendations for mind-body practices like meditation or hypnosis. Referral to other evidence-based modalities is utilized when needed, such as acupuncture or bodywork.

Integrative medicine may be a good fit for those who are interested in taking a deeper look at the cause of their diseases/symptoms and for those who are willing to make some changes to their lifestyle to achieve optimal health or to reduce their medications.

Integrative Medicine is a specialty service, and like most other specialties, you will still need a PCP. In some cases, it may be possible for your Integrative Medicine specialist to act as both.

Cheryl Beighle, MD, provides pediatric care at Marysville, Shoreline, and integrative cancer care for adults at Providence Regional Cancer Partnership Everett. To schedule an appointment, call 360-651-7492 for Marysville, 206-401-3200 for Shoreline and 425-297-5560 for the Cancer Partnership.

The rest is here:
Integrative Medicine | The Everett Clinic

Read More...

Center for Integrative Medicine | Wake Forest Baptist Health

November 15th, 2018 1:46 am

The Consortium of Academic Health Centers for Integrative Medicine defines integrative medicine as a system of comprehensive care that emphasizes wellness and healing of the whole person, with special emphasis on patient participation, and attention to mental and spiritual health. The knowledge and use of complementary and alternative medicine is an important aspect of integrative medicine.

In 2005, Wake Forest Baptist was one of the first 35 academic health centers in North America to be accepted into the Consortium.

Today, the Center oversees a collaboration of educational, community outreach, and research activities focusing on wellness and healing, including acupuncture, the arts, music, and the environment, communication and counseling skills, dietary supplements and herbal medicine, Healing Touch, massage therapy, mind-body, music, nutrition, stress management, tai chi and qi gong and yoga.

Wake Forest Baptist Health now offers patients integrative medicine services. At this new clinic, physicians and healers work side by side to provide collaborative services to address diverse health conditions. We partner with patients of all ages to provide whole person, preventative care to improve overall health and wellbeing. Physicians with specialty training in integrative medicine, internal medicine, family medicine, neurology, pain management, pediatrics, and physical medicine and rehabilitation collaborate with professionals providing acupuncture, psychology, nutrition and integrative energy therapies in an effort to provide patients with comprehensive, evidence based care.

Our services are commonly used to help treat a variety of health conditions, including acute or chronic pain, menopausal-related symptoms, allergies, gastrointestinal symptoms, anxiety, and fatigue, just to name a few. Our Integrative Medicine specialists can help determine if our services are right for your specific health condition.

The Integrative Medicine Clinic is located near Pavilions Shopping Center in Winston-Salem, at 755 Highland Oaks Drive.

See the original post here:
Center for Integrative Medicine | Wake Forest Baptist Health

Read More...

Page 891«..1020..890891892893..900910..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick